Hyaluronic Acid: Molecular Mechanisms and Therapeutic Trajectory
Hyaluronic acid (also known as hyaluronan or hyaluronate) is naturally found in many tissues and fluids, but more abundantly in articular cartilage and synovial fluid (SF). Hyaluronic acid (HA) content varies widely in different joints and species. HA is a non-sulfated, naturally occurring non-prote...
Saved in:
Published in | Frontiers in veterinary science Vol. 6; p. 192 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
25.06.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 2297-1769 2297-1769 |
DOI | 10.3389/fvets.2019.00192 |
Cover
Abstract | Hyaluronic acid (also known as hyaluronan or hyaluronate) is naturally found in many tissues and fluids, but more abundantly in articular cartilage and synovial fluid (SF). Hyaluronic acid (HA) content varies widely in different joints and species. HA is a non-sulfated, naturally occurring non-protein glycosaminoglycan (GAG), with distinct physico-chemical properties, produced by synoviocytes, fibroblasts, and chondrocytes. HA has an important role in the biomechanics of normal SF, where it is partially responsible for lubrication and viscoelasticity of the SF. The concentration of HA and its molecular weight (MW) decline as osteoarthritis (OA) progresses with aging. For that reason, HA has been used for more than four decades in the treatment of OA in dogs, horses and humans. HA produces anti-arthritic effects via multiple mechanisms involving receptors, enzymes and other metabolic pathways. HA is also used in the treatment of ophthalmic, dermal, burns, wound repair, and other health conditions. The MW of HA appears to play a critical role in the formulation of the products used in the treatment of diseases. This review provides a mechanism-based rationale for the use of HA in some disease conditions with special reference to OA. |
---|---|
AbstractList | Hyaluronic acid (also known as hyaluronan or hyaluronate) is naturally found in many tissues and fluids, but more abundantly in articular cartilage and synovial fluid (SF). Hyaluronic acid (HA) content varies widely in different joints and species. HA is a non-sulfated, naturally occurring non-protein glycosaminoglycan (GAG), with distinct physico-chemical properties, produced by synoviocytes, fibroblasts, and chondrocytes. HA has an important role in the biomechanics of normal SF, where it is partially responsible for lubrication and viscoelasticity of the SF. The concentration of HA and its molecular weight (MW) decline as osteoarthritis (OA) progresses with aging. For that reason, HA has been used for more than four decades in the treatment of OA in dogs, horses and humans. HA produces anti-arthritic effects via multiple mechanisms involving receptors, enzymes and other metabolic pathways. HA is also used in the treatment of ophthalmic, dermal, burns, wound repair, and other health conditions. The MW of HA appears to play a critical role in the formulation of the products used in the treatment of diseases. This review provides a mechanism-based rationale for the use of HA in some disease conditions with special reference to OA. Hyaluronic acid (also known as hyaluronan or hyaluronate) is naturally found in many tissues and fluids, but more abundantly in articular cartilage and synovial fluid (SF). Hyaluronic acid (HA) content varies widely in different joints and species. HA is a non-sulfated, naturally occurring non-protein glycosaminoglycan (GAG), with distinct physico-chemical properties, produced by synoviocytes, fibroblasts, and chondrocytes. HA has an important role in the biomechanics of normal SF, where it is partially responsible for lubrication and viscoelasticity of the SF. The concentration of HA and its molecular weight (MW) decline as osteoarthritis (OA) progresses with aging. For that reason, HA has been used for more than four decades in the treatment of OA in dogs, horses and humans. HA produces anti-arthritic effects via multiple mechanisms involving receptors, enzymes and other metabolic pathways. HA is also used in the treatment of ophthalmic, dermal, burns, wound repair, and other health conditions. The MW of HA appears to play a critical role in the formulation of the products used in the treatment of diseases. This review provides a mechanism-based rationale for the use of HA in some disease conditions with special reference to OA.Hyaluronic acid (also known as hyaluronan or hyaluronate) is naturally found in many tissues and fluids, but more abundantly in articular cartilage and synovial fluid (SF). Hyaluronic acid (HA) content varies widely in different joints and species. HA is a non-sulfated, naturally occurring non-protein glycosaminoglycan (GAG), with distinct physico-chemical properties, produced by synoviocytes, fibroblasts, and chondrocytes. HA has an important role in the biomechanics of normal SF, where it is partially responsible for lubrication and viscoelasticity of the SF. The concentration of HA and its molecular weight (MW) decline as osteoarthritis (OA) progresses with aging. For that reason, HA has been used for more than four decades in the treatment of OA in dogs, horses and humans. HA produces anti-arthritic effects via multiple mechanisms involving receptors, enzymes and other metabolic pathways. HA is also used in the treatment of ophthalmic, dermal, burns, wound repair, and other health conditions. The MW of HA appears to play a critical role in the formulation of the products used in the treatment of diseases. This review provides a mechanism-based rationale for the use of HA in some disease conditions with special reference to OA. |
Author | Lall, Rajiv Sinha, Anita Gupta, Ramesh C. Srivastava, Ajay |
AuthorAffiliation | 2 Vets Plus, Inc. , Menomonie, WI , United States 1 Toxicology Department, Breathitt Veterinary Center, Murray State University , Hopkinsville, KY , United States |
AuthorAffiliation_xml | – name: 1 Toxicology Department, Breathitt Veterinary Center, Murray State University , Hopkinsville, KY , United States – name: 2 Vets Plus, Inc. , Menomonie, WI , United States |
Author_xml | – sequence: 1 givenname: Ramesh C. surname: Gupta fullname: Gupta, Ramesh C. – sequence: 2 givenname: Rajiv surname: Lall fullname: Lall, Rajiv – sequence: 3 givenname: Ajay surname: Srivastava fullname: Srivastava, Ajay – sequence: 4 givenname: Anita surname: Sinha fullname: Sinha, Anita |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31294035$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kUtrGzEUhUVIaR7NPqsyy27s6j2jLkpDaJpAQjfuWtyR7sQy45ErzQT87yvbSUkK3Uji6pzvXDhn5HiIAxJyyehciMZ87p5wzHNOmZnTcvAjcsq5qWes1ub41fuEXOS8okWjZC0a-p6cCMaNpEKdkm-3W-inFIfgqisX_JfqIfboph5S9YBuCUPI61zB4KvFEhNscBqLdJFghW6MafuBvOugz3jxfJ-TXzffF9e3s_ufP-6ur-5nTmo-znztpDKcMTCMg6kF77x0EmqBrXeCKtN2vlYaJHLoBAWmWiplS1VZW4MR5-TuwPURVnaTwhrS1kYIdj-I6dFCKqv1aLEpKc43VLRKYqNNg13dGE-1NuhYW1hfD6zN1K7ROxzGBP0b6NufISztY3yyWlPBalUAn54BKf6eMI92HbLDvocB45Qt50ozyhqhi_Tj66y_IS8VFIE-CFyKOSfsrAsjjCHuokNvGbW7uu2-brur2-7rLkb6j_GF_V_LH-Zlrgw |
CitedBy_id | crossref_primary_10_1016_j_berh_2023_101848 crossref_primary_10_1016_j_tcam_2022_100653 crossref_primary_10_4103_JISPRM_000139 crossref_primary_10_1016_j_foodhyd_2020_106110 crossref_primary_10_1016_j_hermed_2023_100629 crossref_primary_10_1007_s40141_024_00458_2 crossref_primary_10_2147_JEP_S237479 crossref_primary_10_1016_j_ijbiomac_2023_124902 crossref_primary_10_1016_j_gastrohep_2022_10_013 crossref_primary_10_3389_fphar_2022_945876 crossref_primary_10_3390_molecules27103267 crossref_primary_10_1016_j_heliyon_2021_e07572 crossref_primary_10_1111_exd_14638 crossref_primary_10_1186_s12951_022_01758_2 crossref_primary_10_3390_ph16091293 crossref_primary_10_3390_pr9020241 crossref_primary_10_1016_j_anicom_2021_03_001 crossref_primary_10_2478_ama_2024_0073 crossref_primary_10_1007_s11010_021_04195_1 crossref_primary_10_3390_ijms25020768 crossref_primary_10_1016_j_jddst_2021_102417 crossref_primary_10_3390_plants11070873 crossref_primary_10_1016_j_biomaterials_2024_122845 crossref_primary_10_1007_s00784_023_05227_4 crossref_primary_10_3389_fcell_2021_661532 crossref_primary_10_1016_j_ijbiomac_2020_02_214 crossref_primary_10_1080_10406638_2021_1995011 crossref_primary_10_1016_j_ijpharm_2022_121523 crossref_primary_10_1080_00914037_2024_2360956 crossref_primary_10_1016_j_ijpharm_2024_124238 crossref_primary_10_1080_09205063_2024_2416293 crossref_primary_10_1016_j_mser_2023_100760 crossref_primary_10_5124_jkma_2023_66_8_479 crossref_primary_10_1515_epoly_2022_0086 crossref_primary_10_3390_pharmaceutics14071479 crossref_primary_10_3390_polym16101396 crossref_primary_10_1016_j_jconrel_2025_113639 crossref_primary_10_1016_j_apsb_2021_03_016 crossref_primary_10_1021_acsanm_4c01406 crossref_primary_10_1002_adfm_202400585 crossref_primary_10_1007_s00296_020_04681_7 crossref_primary_10_1016_j_jos_2024_11_010 crossref_primary_10_3389_fcimb_2024_1303645 crossref_primary_10_3390_molecules29163732 crossref_primary_10_2174_18742106_v17_230619_2022_115 crossref_primary_10_1002_adhm_202101389 crossref_primary_10_3390_pharmaceutics13070944 crossref_primary_10_3389_fvets_2022_890704 crossref_primary_10_1016_j_cvsm_2022_03_004 crossref_primary_10_1016_j_jddst_2024_105503 crossref_primary_10_1021_acsabm_0c00765 crossref_primary_10_1039_D0TB01005G crossref_primary_10_3390_cells9092113 crossref_primary_10_1016_j_bbrc_2023_05_028 crossref_primary_10_33667_2078_5631_2024_29_29_38 crossref_primary_10_2139_ssrn_4191037 crossref_primary_10_3390_nu15163573 crossref_primary_10_11648_j_ass_20241201_13 crossref_primary_10_14193_jkfas_2022_26_2_71 crossref_primary_10_1002_adfm_202413525 crossref_primary_10_1021_acsabm_0c00537 crossref_primary_10_1016_j_drup_2022_100865 crossref_primary_10_3390_pharmaceutics14102092 crossref_primary_10_1590_acb361201 crossref_primary_10_3390_jpm11040303 crossref_primary_10_17116_kurort20229904120 crossref_primary_10_1002_term_3086 crossref_primary_10_1002_ardp_202400903 crossref_primary_10_3390_life13071460 crossref_primary_10_1111_eve_13719 crossref_primary_10_1002_smll_202202146 crossref_primary_10_1016_j_sdentj_2023_01_008 crossref_primary_10_14412_1996_7012_2023_2_50_56 crossref_primary_10_3390_chemosensors11070367 crossref_primary_10_1002_asia_202200797 crossref_primary_10_4103_bbrj_bbrj_318_24 crossref_primary_10_1016_j_mtbio_2022_100453 crossref_primary_10_3390_jpm14080784 crossref_primary_10_1016_j_ijbiomac_2020_09_255 crossref_primary_10_1088_1748_605X_ac8e41 crossref_primary_10_1016_j_ijpharm_2022_121939 crossref_primary_10_3389_fbioe_2022_913912 crossref_primary_10_1016_j_jcot_2021_101601 crossref_primary_10_3389_fbioe_2022_907356 crossref_primary_10_1016_j_carbpol_2023_121099 crossref_primary_10_3390_polym14040839 crossref_primary_10_1016_j_phymed_2023_154824 crossref_primary_10_3390_pharmaceutics15051364 crossref_primary_10_3390_ijms22126391 crossref_primary_10_3390_ijms24031836 crossref_primary_10_1007_s43450_024_00593_w crossref_primary_10_3390_ijms24065606 crossref_primary_10_1186_s13018_024_04952_0 crossref_primary_10_3390_jcm12062359 crossref_primary_10_1177_19476035211021903 crossref_primary_10_1021_acsomega_4c01911 crossref_primary_10_1007_s12178_022_09740_z crossref_primary_10_2174_1874364102115010299 crossref_primary_10_1177_03635465241302820 crossref_primary_10_14412_1996_7012_2024_3_107_113 crossref_primary_10_1007_s00264_020_04838_w crossref_primary_10_3389_fbioe_2024_1309541 crossref_primary_10_3390_ijms232113066 crossref_primary_10_3390_polym12081800 crossref_primary_10_1039_D1TB00268F crossref_primary_10_3390_polym13193429 crossref_primary_10_1016_j_micromeso_2023_112903 crossref_primary_10_3390_biom13121737 crossref_primary_10_1016_j_jevs_2019_102909 crossref_primary_10_1016_j_ijbiomac_2021_07_067 crossref_primary_10_3390_molecules28020809 crossref_primary_10_5339_jemtac_2023_midc_9 crossref_primary_10_1007_s00784_023_05092_1 crossref_primary_10_1007_s40820_021_00670_y crossref_primary_10_4103_jpbs_jpbs_63_23 crossref_primary_10_7759_cureus_36123 crossref_primary_10_1039_D2RA04984H crossref_primary_10_1016_j_molmed_2020_10_006 crossref_primary_10_1055_s_0040_1720072 crossref_primary_10_1097_MRR_0000000000000411 crossref_primary_10_3389_fbioe_2022_1080430 crossref_primary_10_3389_fphar_2022_907516 crossref_primary_10_1186_s12951_024_02783_z crossref_primary_10_1590_1413_785220223005e250414 crossref_primary_10_1016_j_joca_2022_11_005 crossref_primary_10_1177_03635465231191779 crossref_primary_10_36740_WLek202009114 crossref_primary_10_1038_s41467_023_43623_2 crossref_primary_10_3390_app14135872 crossref_primary_10_3390_ijms241814130 crossref_primary_10_1016_j_envres_2023_116467 crossref_primary_10_3390_molecules26092485 crossref_primary_10_1002_cpz1_688 crossref_primary_10_3390_ani11113271 crossref_primary_10_3390_foods12071400 crossref_primary_10_1016_j_ijbiomac_2024_138620 crossref_primary_10_1021_acs_biomac_4c00985 crossref_primary_10_1134_S1068162023020103 crossref_primary_10_1002_adhm_202302551 crossref_primary_10_3390_pharmaceutics16121604 crossref_primary_10_3389_fbioe_2021_603444 crossref_primary_10_3390_polym14173442 crossref_primary_10_1016_j_carbpol_2021_117757 crossref_primary_10_1063_5_0129530 crossref_primary_10_1080_15548627_2023_2181614 crossref_primary_10_3390_biomedicines10020202 crossref_primary_10_3390_molecules24234289 crossref_primary_10_3390_jpm13030429 crossref_primary_10_21070_acopen_9_2024_10382 crossref_primary_10_1002_adtp_201900206 crossref_primary_10_1002_adfm_202202468 crossref_primary_10_17816_KMJ568204 crossref_primary_10_3390_biomedicines12102292 crossref_primary_10_1021_acsami_1c05574 crossref_primary_10_1016_j_cis_2021_102563 crossref_primary_10_3390_ijms24076078 crossref_primary_10_1002_jbm_a_37766 crossref_primary_10_3390_molecules27175619 crossref_primary_10_3390_lubricants12040126 crossref_primary_10_3390_ani13193030 crossref_primary_10_1016_j_bioactmat_2022_12_027 crossref_primary_10_3390_ma17215184 crossref_primary_10_3390_biomedicines13010106 crossref_primary_10_2174_1389201023666220413091055 crossref_primary_10_21653_tjpr_1329550 crossref_primary_10_3389_fbioe_2022_1057429 crossref_primary_10_1186_s40634_020_00256_4 crossref_primary_10_1007_s00106_023_01369_9 crossref_primary_10_1016_j_matpr_2023_09_052 crossref_primary_10_1016_j_ymgme_2022_106966 crossref_primary_10_1002_btpr_3325 crossref_primary_10_1093_burnst_tkac058 crossref_primary_10_1097_MD_0000000000037506 crossref_primary_10_3389_fphar_2024_1355279 crossref_primary_10_1016_j_ijbiomac_2024_135553 crossref_primary_10_1080_10601325_2023_2265961 crossref_primary_10_1021_acs_biomac_3c00351 crossref_primary_10_3390_biom11101518 crossref_primary_10_3390_ijms222111503 crossref_primary_10_1002_adma_202006362 crossref_primary_10_3389_fnut_2022_879354 crossref_primary_10_3390_biomedicines13020376 crossref_primary_10_1016_j_ijbiomac_2021_05_086 crossref_primary_10_1128_mbio_00236_22 crossref_primary_10_3389_fbioe_2022_794037 crossref_primary_10_3390_biomedicines11041061 crossref_primary_10_1002_mas_21737 crossref_primary_10_1016_j_gastre_2022_10_009 crossref_primary_10_17721_1728_2748_2023_94_10_14 crossref_primary_10_3389_fendo_2020_00285 crossref_primary_10_1016_j_ijbiomac_2024_137840 crossref_primary_10_1016_j_carbpol_2020_116364 crossref_primary_10_1016_j_arthro_2021_06_033 crossref_primary_10_3390_biomimetics7040250 crossref_primary_10_1007_s10126_024_10361_5 crossref_primary_10_3390_ma15010234 crossref_primary_10_3390_polym16233410 crossref_primary_10_1016_j_comptc_2022_113761 crossref_primary_10_1016_j_mtbio_2023_100597 crossref_primary_10_1016_j_ijbiomac_2023_124484 crossref_primary_10_7554_eLife_57438 crossref_primary_10_1002_app_54310 crossref_primary_10_3390_cells9071743 crossref_primary_10_1016_j_nano_2022_102560 crossref_primary_10_1080_14686996_2022_2156257 crossref_primary_10_3390_pharmaceutics15051522 crossref_primary_10_1002_jbio_202400024 crossref_primary_10_1002_adhm_202001410 crossref_primary_10_3390_ijms252312486 crossref_primary_10_1177_10225536231156699 crossref_primary_10_1515_hsz_2021_0174 crossref_primary_10_3390_gels8040211 crossref_primary_10_1186_s13018_024_05144_6 crossref_primary_10_1016_j_scienta_2023_112539 crossref_primary_10_1155_2023_1868943 crossref_primary_10_1016_j_fbio_2024_104912 crossref_primary_10_1016_j_jorep_2023_100157 crossref_primary_10_1007_s10354_021_00831_z crossref_primary_10_1016_j_ijbiomac_2023_127607 crossref_primary_10_1016_j_bioadv_2024_214054 crossref_primary_10_32895_UMP_MPR_8_3_22 crossref_primary_10_1021_acs_jctc_3c01088 crossref_primary_10_1038_s41584_024_01125_5 crossref_primary_10_1186_s43094_021_00281_9 crossref_primary_10_1007_s42242_022_00198_z crossref_primary_10_1016_j_joca_2022_05_007 crossref_primary_10_1002_mabi_202100304 crossref_primary_10_1038_s41598_025_86320_4 crossref_primary_10_1016_j_jobcr_2024_02_010 crossref_primary_10_3389_fimmu_2023_1269960 crossref_primary_10_18502_ijrm_v21i12_15034 crossref_primary_10_1002_wnan_1780 crossref_primary_10_1039_D3SM01301D crossref_primary_10_1016_j_carpta_2023_100392 crossref_primary_10_1097_JCMA_0000000000000489 crossref_primary_10_1016_j_artd_2022_09_003 crossref_primary_10_1007_s00784_021_04241_8 crossref_primary_10_3390_molecules26040878 crossref_primary_10_1007_s11010_022_04491_4 crossref_primary_10_1016_j_mtbio_2024_101353 crossref_primary_10_3390_ijms22158005 crossref_primary_10_1016_j_knee_2021_02_019 crossref_primary_10_1016_j_medntd_2024_100320 crossref_primary_10_17586_2687_0568_2024_6_2_67_79 crossref_primary_10_3390_jox14030072 crossref_primary_10_3390_biomimetics9080499 crossref_primary_10_3390_metabo11030132 crossref_primary_10_1016_j_mser_2021_100641 crossref_primary_10_1016_j_jddst_2024_106183 crossref_primary_10_1111_jerd_12694 crossref_primary_10_33380_2305_2066_2024_13_1_1538 crossref_primary_10_12688_f1000research_133259_1 crossref_primary_10_1016_j_cej_2023_147788 crossref_primary_10_3390_ijms23116038 crossref_primary_10_3390_molecules26154429 crossref_primary_10_1016_j_carbpol_2023_120880 crossref_primary_10_3390_gels10080510 crossref_primary_10_1080_14756366_2021_1956487 crossref_primary_10_1002_adem_202101541 crossref_primary_10_3390_antiox11040664 crossref_primary_10_1016_j_intimp_2023_110878 crossref_primary_10_1002_adbi_202300621 crossref_primary_10_3390_gels9060476 crossref_primary_10_1016_j_engreg_2020_10_001 crossref_primary_10_3390_biomedicines9111551 crossref_primary_10_1007_s10853_022_07072_4 crossref_primary_10_3390_gels9100808 crossref_primary_10_1115_1_4047628 crossref_primary_10_1016_j_jcjp_2024_100187 crossref_primary_10_3390_pharmaceutics15092247 crossref_primary_10_1016_j_ijbiomac_2024_132454 crossref_primary_10_2174_1381612828666220328122539 crossref_primary_10_3390_ijms24044200 crossref_primary_10_3390_polym14122365 crossref_primary_10_3390_biom10121612 crossref_primary_10_3389_fimmu_2023_1327852 crossref_primary_10_1186_s12891_025_08488_0 crossref_primary_10_1248_bpb_b21_00763 crossref_primary_10_1002_mco2_554 crossref_primary_10_1186_s13765_024_00976_6 crossref_primary_10_4103_tdj_tdj_5_22 crossref_primary_10_1002_jor_25340 crossref_primary_10_1002_dta_3761 crossref_primary_10_1111_hae_14182 crossref_primary_10_1007_s00167_023_07519_4 crossref_primary_10_1016_j_fbio_2024_105399 crossref_primary_10_1007_s00264_020_04789_2 crossref_primary_10_1177_02683555221129555 crossref_primary_10_3390_pharmaceutics15061708 crossref_primary_10_1007_s10719_020_09962_8 crossref_primary_10_3390_app12063165 crossref_primary_10_1186_s43094_024_00735_w crossref_primary_10_3389_fnut_2023_1275199 crossref_primary_10_47360_1995_4484_2021_450_454 crossref_primary_10_1093_rheumatology_keab020 crossref_primary_10_1177_19476035221077404 crossref_primary_10_3389_fbioe_2024_1415527 crossref_primary_10_4103_bbrj_bbrj_301_23 crossref_primary_10_1002_jor_25577 crossref_primary_10_1016_j_jcis_2023_12_166 crossref_primary_10_1016_j_jormas_2022_05_007 crossref_primary_10_1021_acsabm_0c01364 crossref_primary_10_1002_JPER_24_0093 crossref_primary_10_1016_j_gendis_2023_04_039 crossref_primary_10_1016_j_matdes_2023_112075 crossref_primary_10_2106_JBJS_21_01043 crossref_primary_10_3390_molecules29030739 crossref_primary_10_3390_jcm13175176 crossref_primary_10_3390_ijms24010816 crossref_primary_10_1016_j_bbcan_2022_188703 crossref_primary_10_1016_j_cvsm_2023_02_006 crossref_primary_10_1016_j_ijpharm_2022_122468 crossref_primary_10_3390_ijms22136758 crossref_primary_10_3390_biomedicines13010039 crossref_primary_10_1007_s10719_019_09904_z crossref_primary_10_3390_ma15020463 crossref_primary_10_34883_PI_2021_11_2_015 crossref_primary_10_1016_j_jddst_2022_103564 crossref_primary_10_3390_medicina57101088 crossref_primary_10_3390_jfb14090455 crossref_primary_10_3390_polym13010095 crossref_primary_10_1002_jbm_b_35254 crossref_primary_10_3390_pharmaceutics15071883 crossref_primary_10_1016_j_cej_2022_139491 crossref_primary_10_32634_0869_8155_2022_358_4_16_20 crossref_primary_10_3390_molecules25112649 crossref_primary_10_1016_j_ijbiomac_2024_135923 crossref_primary_10_2174_0115672018275983231207101222 crossref_primary_10_1016_j_ijpx_2023_100170 crossref_primary_10_3390_pharmaceutics13081108 crossref_primary_10_55095_achot2021_015 crossref_primary_10_1007_s40265_022_01773_5 crossref_primary_10_1016_j_ijbiomac_2024_132890 crossref_primary_10_3390_antiox10091452 crossref_primary_10_3389_fimmu_2024_1395187 crossref_primary_10_1371_journal_pone_0289956 crossref_primary_10_1016_j_bioadv_2023_213733 crossref_primary_10_1186_s12929_023_00962_y crossref_primary_10_1016_j_carbpol_2020_116787 crossref_primary_10_3390_pharmaceutics14020305 crossref_primary_10_1016_j_jhep_2023_08_010 crossref_primary_10_7759_cureus_31592 crossref_primary_10_1016_j_ijbiomac_2024_133855 crossref_primary_10_21518_2079_701X_2021_10_123_132 crossref_primary_10_3390_gels9070588 crossref_primary_10_3389_fvets_2020_00265 crossref_primary_10_7759_cureus_45646 crossref_primary_10_3390_ph14090849 crossref_primary_10_3390_biom10010063 crossref_primary_10_1002_adhm_202203104 crossref_primary_10_1016_j_carpta_2022_100266 crossref_primary_10_3889_oamjms_2022_9640 crossref_primary_10_3389_fphar_2022_883216 crossref_primary_10_1002_slct_202402035 crossref_primary_10_1016_j_colsurfb_2021_112208 crossref_primary_10_3390_ani12111401 crossref_primary_10_1016_j_carbpol_2025_123307 crossref_primary_10_1186_s12891_022_05767_y crossref_primary_10_1140_epjp_s13360_020_00976_7 crossref_primary_10_1002_marc_202200449 crossref_primary_10_1016_j_cej_2022_139717 crossref_primary_10_1002_adma_202312226 crossref_primary_10_1039_D1CS00127B crossref_primary_10_1039_D2BM01133F crossref_primary_10_1111_srt_70068 crossref_primary_10_3390_polym15193940 crossref_primary_10_1016_j_carpta_2022_100275 crossref_primary_10_1016_j_jconrel_2021_07_002 crossref_primary_10_1002_jor_25960 crossref_primary_10_1021_acsomega_4c03463 crossref_primary_10_3390_md19010010 crossref_primary_10_1021_acsfoodscitech_1c00152 crossref_primary_10_1080_00914037_2024_2316172 crossref_primary_10_3390_cimb46050251 crossref_primary_10_1039_D2BM01154A crossref_primary_10_3746_pnf_2023_28_1_50 crossref_primary_10_3390_pharmaceutics14102235 crossref_primary_10_3390_ijms23020773 crossref_primary_10_1007_s12257_020_0343_8 crossref_primary_10_3390_ijms24010103 crossref_primary_10_3390_ijms22179367 crossref_primary_10_14412_1996_7012_2023_4_120_137 crossref_primary_10_3390_medicina59112047 crossref_primary_10_1016_j_ijbiomac_2023_128695 crossref_primary_10_1016_j_drudis_2021_01_029 crossref_primary_10_1039_D4RA03809F crossref_primary_10_1016_j_lfs_2022_120591 crossref_primary_10_3390_ph16101429 crossref_primary_10_14412_1996_7012_2023_1_93_100 crossref_primary_10_1007_s10924_021_02052_2 crossref_primary_10_1186_s12917_023_03777_z crossref_primary_10_1021_acsbiomaterials_1c00658 crossref_primary_10_3390_pharmaceutics15020695 crossref_primary_10_1016_j_ijbiomac_2020_07_126 crossref_primary_10_1016_j_ijbiomac_2024_130424 crossref_primary_10_3389_fnut_2024_1379982 crossref_primary_10_1002_adfm_202113380 crossref_primary_10_1016_j_bioactmat_2024_06_007 crossref_primary_10_1016_j_carres_2025_109384 crossref_primary_10_1016_j_jddst_2022_104119 crossref_primary_10_3390_biomedicines9111732 crossref_primary_10_3390_gels9020150 crossref_primary_10_1186_s12891_020_03876_0 crossref_primary_10_3389_fimmu_2022_996103 crossref_primary_10_3390_technologies8040071 crossref_primary_10_59324_ejtas_2024_2_6__35 crossref_primary_10_1002_pol_20220734 crossref_primary_10_3390_cosmetics9030054 crossref_primary_10_1002_jor_24889 crossref_primary_10_1007_s00256_022_04178_3 crossref_primary_10_3390_cimb46090621 crossref_primary_10_1002_btm2_10443 crossref_primary_10_3390_ijms221910313 crossref_primary_10_1088_1758_5090_ac2cd7 crossref_primary_10_3390_polym12051002 crossref_primary_10_3390_jpm13121647 crossref_primary_10_1038_s41598_022_21398_8 crossref_primary_10_3390_pharmaceutics14081628 crossref_primary_10_1002_adhm_202100777 crossref_primary_10_1016_j_ijbiomac_2024_132700 crossref_primary_10_3390_ijms23158114 crossref_primary_10_1016_j_jsps_2020_07_010 crossref_primary_10_3390_polym13111796 crossref_primary_10_1016_j_addr_2024_115217 crossref_primary_10_3389_fimmu_2021_660488 crossref_primary_10_1155_2021_2989054 crossref_primary_10_1016_j_bprint_2022_e00205 crossref_primary_10_5937_scriptamed55_49700 crossref_primary_10_1007_s00239_024_10204_w crossref_primary_10_15430_JCP_2023_28_4_160 crossref_primary_10_30629_0023_2149_2022_100_11_12_527_534 crossref_primary_10_1016_j_actbio_2023_10_016 crossref_primary_10_1016_j_jep_2023_117560 crossref_primary_10_1096_fj_202200485R crossref_primary_10_5005_jp_journals_10015_2446 crossref_primary_10_1177_1759720X231157043 crossref_primary_10_1007_s43994_023_00045_6 crossref_primary_10_3390_cells9051232 crossref_primary_10_1088_1748_605X_ac3d74 crossref_primary_10_1155_2022_8332631 |
Cites_doi | 10.1186/ar1499 10.1016/0014-4827(83)90458-5 10.1001/jama.290.23.3115 10.1039/C7TB01895A 10.1007/BF03191112 10.1101/gad.11.8.996 10.11138/ccmbm/2016.13.2.131 10.1002/art.1780330913 10.1016/S1471-4906(03)00029-2 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B 10.1074/jbc.M402424200 10.1002/jor.20524 10.1016/S0021-9258(18)75338-6 10.1186/s12937-016-0128-2 10.1016/S1357-2725(02)00301-1 10.1007/978-3-030-04624-8_24 10.1002/jor.1100030203 10.1002/art.10056 10.18433/J3K89D 10.1097/01.bor.0000172800.49120.97 10.1084/jem.172.1.69 10.2478/intox-2013-0019 10.2174/138920108785161569 10.1056/NEJMct1215534 10.1016/S0049-0172(10)80016-2 10.1016/j.joca.2004.11.010 10.2460/ajvr.69.12.1569 10.1016/j.matbio.2009.11.002 10.1016/j.matbio.2018.02.005 10.18632/oncotarget.8926 10.2165/00003495-199447030-00009 10.1074/jbc.M202404200 10.1074/jbc.M804178200 10.1080/00480169.1979.34585 10.1074/jbc.C300173200 10.1016/S0022-5193(86)80076-5 10.1016/S0049-0172(10)80015-0 10.1111/j.1440-1681.1984.tb00235.x 10.1016/j.mito.2004.07.022 10.1096/fasebj.6.7.1563592 10.2460/ajvr.1994.55.05.710 10.1016/j.drudis.2018.05.023 10.1016/j.freeradbiomed.2018.09.025 10.1002/acr.21898 10.1002/art.23103 10.1100/2012/167928 10.1177/0363546508326984 10.1254/fpj.92.17 10.1620/tjem.187.1 10.1038/eye.1998.213 10.1155/2013/460437 10.1254/fpj.100.359 10.4103/1947-2714.112473 10.1007/s00296-004-0547-9 10.1042/bj2670185 10.1046/j.1365-2796.1997.00171.x 10.1016/j.biocel.2017.12.003 10.1074/jbc.C600138200 10.4155/tde.15.55 10.1007/s13534-017-0010-y 10.1016/0009-8981(76)90008-5 10.1038/nrrheum.2010.196 10.1002/art.23026 10.1186/1475-2859-10-99 10.1097/TA.0b013e3181a92cf8 10.1016/S0737-0806(85)80102-7 10.1302/0301-620X.58B1.131804 10.1620/tjem.204.99 10.1099/00221287-15-3-485 10.18632/oncoscience.150 10.1006/bbrc.1994.1426 10.1097/01.blo.0000143804.26638.82 10.2165/00002018-200023020-00003 10.1016/j.jbspin.2005.03.005 10.1002/art.11421 10.18632/oncotarget.20615 10.1155/2011/969012 10.1097/00003086-200104000-00021 10.3349/ymj.2009.50.6.832 10.1042/bj2140777 10.3390/polym6020346 10.1177/117954411000300001 10.1111/j.1365-2885.1979.tb00403.x 10.1016/S0149-2918(00)80010-7 10.1177/43.2.7529785 10.3390/ijms161125943 10.5772/26818 10.1111/j.2042-3292.1997.tb01747.x 10.1016/j.carbpol.2017.09.017 10.1111/j.2042-3306.1995.tb04070.x 10.1016/S0891-8422(23)00955-2 10.1016/j.joca.2009.03.002 10.1097/MD.0000000000004315 10.2147/IJGM.S5495 10.1016/j.chest.2017.12.016 10.1158/0008-5472.CAN-10-4610 10.1089/15396850360495718 10.1053/joca.1998.0207 10.1186/ar748 10.2106/00004623-200403000-00012 10.1016/j.biomaterials.2013.07.062 10.1021/jf8017029 10.1016/0049-0172(89)90080-2 10.1111/j.1742-481X.2012.01057.x 10.1016/0092-8674(90)90694-A 10.1136/annrheumdis-2011-200972 10.1002/cbf.290120409 10.1021/ja01636a010 10.1089/jmf.2013.0174 10.1111/j.1463-5224.2010.00771.x 10.1053/joca.2000.0400 10.1007/PL00005742 10.1152/ajpheart.1990.259.2.H532 10.1016/S0955-0674(00)00135-6 10.1016/S0161-6420(84)34341-X 10.1002/app.42194 10.1155/2015/563818 10.1016/S1357-2725(01)00166-2 10.1002/art.20004 10.1002/art.34674 10.1371/journal.pone.0088479 10.1016/B978-0-12-800092-2.00002-2 10.1186/s40634-016-0060-6 10.1046/j.1524-475X.1999.00079.x 10.1093/glycob/cwn006 10.1016/j.knee.2008.02.012 10.1002/jbm.a.35437 10.1007/s000110050132 10.1186/ar2574 10.1038/icb.1996.32 10.1023/B:APPT.0000025803.17498.26 10.1023/A:1020185404126 10.1097/BLO.0b013e31815873f9 10.1074/jbc.M110.104950 10.1080/09205063.2015.1072902 10.1007/BF01987905 10.1136/ard.57.11.637 10.1097/BOR.0b013e32830aba34 10.1089/1080768042727873 10.3390/polym10070701 10.1002/jor.1100180313 10.1089/jmf.2016.3787 10.1074/jbc.M102273200 10.3109/1061186X.2015.1052072 10.1007/s00776-008-1279-6 10.1186/BF03547976 10.1242/jcs.03310 10.1142/S021895770200085X 10.7326/0003-4819-157-3-201208070-00473 10.1007/BF03259791 10.1136/ard.2007.086884 10.1517/14656566.9.10.1797 10.1186/1471-2474-12-42 10.1016/S0736-0266(00)90024-X 10.1002/jbm.b.32771 10.1111/j.1743-6109.2006.00119.x 10.1002/art.1780100407 10.1113/jphysiol.1953.sp004842 10.3389/fimmu.2015.00154 10.1158/1078-0432.CCR-07-2019 10.3892/mmr.2016.6035 10.1074/jbc.M109.011999 10.1165/rcmb.2004-0333OC 10.1016/0003-9969(90)90058-I 10.1096/fj.14-259978 10.1097/00003086-199401000-00039 10.1152/ajplung.00116.2014 10.3233/BIR-2011-0596 10.2174/138945007779940025 10.3390/ijms17122146 10.1097/00003086-197110000-00006 10.1186/s13018-016-0346-5 10.1016/S0149-2918(98)80052-0 10.1002/jor.21216 10.1016/j.msec.2017.12.013 10.1016/j.freeradbiomed.2018.08.038 10.1016/j.maturitas.2014.12.003 10.1016/S0049-0172(10)80017-4 10.1126/science.2408340 10.2147/OPTH.S131384 10.1007/s00296-005-0611-0 10.1097/00003086-198904000-00037 10.1053/joca.1998.0216 10.2460/javma.2002.221.944 10.1152/physrev.00052.2009 10.1016/S0945-053X(99)00045-1 10.1007/s11892-012-0297-0 10.1016/j.ymben.2007.09.001 10.1007/s00296-014-3047-6 10.1074/jbc.M002527200 10.1016/B978-0-12-814655-2.00052-9 10.1016/j.biotechadv.2007.07.001 10.1016/j.joca.2012.11.012 10.2147/IJN.S95850 10.1042/bj2560153 10.1016/j.ajo.2009.09.023 10.1359/jbmr.2005.20.1.30 10.1016/S0737-0806(89)80120-0 10.1186/s40169-017-0180-3 10.1172/JCI103585 10.1046/j.1365-2796.1997.00175.x 10.1007/BF00717001 10.1016/j.proghi.2006.02.003 10.1155/2016/2076921 10.2165/00002512-200724080-00002 10.1074/jbc.273.35.22466 10.1097/00003086-198904000-00038 10.1016/j.jcms.2015.04.022 10.1007/s10165-010-0299-1 10.1074/jbc.R100038200 10.1097/00002281-200009000-00022 10.1042/bj2000415 10.3109/03008209009152150 10.1177/1947603512455193 10.17221/1930-VETMED 10.1016/j.joca.2018.09.016 10.1083/jcb.109.2.927 10.1016/B978-0-12-802147-7.00013-9 10.1007/s10067-004-1013-5 10.1111/wrr.12214 10.1002/(SICI)1097-0185(199804)250:4<418::AID-AR4>3.3.CO;2-B 10.1016/S0140-6736(12)61690-0 10.1186/1476-9255-10-26 10.1002/1529-0131(200108)44:8<1800::AID-ART317>3.0.CO;2-1 10.1186/BF03547893 10.1111/j.1756-185X.2011.01618.x 10.18632/oncotarget.3220 10.1016/j.joca.2006.03.008 10.1186/ar623 10.1016/j.joca.2017.02.797 10.1053/rvsc.1999.0328 10.1111/cxo.12073 10.1016/S0304-3959(02)00260-9 10.1078/0171-9335-00392 10.1038/srep12775 10.1016/j.joca.2005.09.003 10.1113/expphysiol.1991.sp003536 10.1016/j.jconrel.2015.01.030 10.3390/pharmaceutics10010033 10.1002/jbm.a.32455 10.3390/molecules22122104 10.1186/s12917-016-0687-7 10.2460/ajvr.77.10.1064 10.1111/jocd.12237 10.3390/polym10101133 10.1053/sarh.2002.33720 10.1111/evj.12521 10.1016/j.addr.2015.10.017 10.1053/joca.1999.0266 10.1038/s41467-018-05787-0 10.1111/1523-1747.ep12396880 10.1046/j.1524-475X.1995.30310.x 10.1016/S1063-4584(05)80319-X 10.1046/j.1365-2796.1997.00170.x 10.1093/glycob/cws218 10.2174/092986709788186138 10.1007/s10753-016-0406-3 10.1002/1529-0131(199806)41:6<976::AID-ART4>3.0.CO;2-R 10.1016/j.optm.2010.08.003 10.1016/j.actbio.2017.03.043 10.1042/bj2500435 10.1016/j.joca.2018.10.001 10.1016/j.joca.2006.05.009 10.1016/S0021-9258(18)50356-2 10.1111/j.1751-0813.1984.tb07125.x 10.1074/jbc.M112.349209 10.1093/rheumatology/ken219 10.1016/S0737-0806(85)80106-4 10.1186/s12951-016-0245-2 10.1016/j.ijbiomac.2014.11.026 10.1038/nrc3254 10.1016/S1063-4584(97)80010-6 10.1016/j.cveq.2007.04.007 10.1002/art.1780401004 10.1016/S1063-4584(03)00119-5 10.1093/rheumatology/41.11.1240 10.1016/S0034-5288(18)32580-3 10.1136/ard.52.11.817 10.1016/j.abb.2016.02.003 |
ContentType | Journal Article |
Copyright | Copyright © 2019 Gupta, Lall, Srivastava and Sinha. 2019 Gupta, Lall, Srivastava and Sinha |
Copyright_xml | – notice: Copyright © 2019 Gupta, Lall, Srivastava and Sinha. 2019 Gupta, Lall, Srivastava and Sinha |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.3389/fvets.2019.00192 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Veterinary Medicine |
EISSN | 2297-1769 |
ExternalDocumentID | oai_doaj_org_article_e81a9cd803b54e8698ef789d0669ec1b PMC6603175 31294035 10_3389_fvets_2019_00192 |
Genre | Journal Article Review |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAYXX ACGFS ACXDI ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV CITATION GROUPED_DOAJ HYE KQ8 M48 M~E OK1 PGMZT RPM ECGQY EYRJQ IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c462t-d7c459211a912a9732fd4c4a73ebdc3059bfd756a4e2af30a15b044b050156a93 |
IEDL.DBID | M48 |
ISSN | 2297-1769 |
IngestDate | Wed Aug 27 01:23:31 EDT 2025 Thu Aug 21 18:41:12 EDT 2025 Thu Sep 04 18:04:11 EDT 2025 Thu Apr 03 07:03:03 EDT 2025 Tue Jul 01 02:58:53 EDT 2025 Thu Apr 24 22:59:54 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | cancer therapy ophthalmic diseases wound healing hyaluronan osteoarthritis viscosupplementation adjuvant therapy hyaluronic acid |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-d7c459211a912a9732fd4c4a73ebdc3059bfd756a4e2af30a15b044b050156a93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Edited by: Nora Mestorino, National University of La Plata, Argentina Reviewed by: Piotr Bełdowski, University of Technology and Life Sciences in Bydgoszcz, Poland; Maria-Rosa Martinez-Larrañaga, Complutense University of Madrid, Spain This article was submitted to Veterinary Pharmacology and Toxicology, a section of the journal Frontiers in Veterinary Science |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fvets.2019.00192 |
PMID | 31294035 |
PQID | 2256101836 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_e81a9cd803b54e8698ef789d0669ec1b pubmedcentral_primary_oai_pubmedcentral_nih_gov_6603175 proquest_miscellaneous_2256101836 pubmed_primary_31294035 crossref_citationtrail_10_3389_fvets_2019_00192 crossref_primary_10_3389_fvets_2019_00192 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-06-25 |
PublicationDateYYYYMMDD | 2019-06-25 |
PublicationDate_xml | – month: 06 year: 2019 text: 2019-06-25 day: 25 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in veterinary science |
PublicationTitleAlternate | Front Vet Sci |
PublicationYear | 2019 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Wang (B182) 2006; 14 Oksala (B272) 1995; 43 Inoue (B296) 1993; 34 Smith (B233) 1998; 41 Goa (B288) 1994; 47 Kirchner (B264) 2006; 14 Martens (B305) 2015; 202 Hamano (B295) 1996; 40 Adams (B128) 1998; 250 George (B58) 1998; 57 Smith (B207) 2008; 47 Santilli (B255) 2016; 13 Reichenbach (B266) 2007; 57 Arnold (B283) 1995; 3 Gupta (B43) 2019 Kuroki (B154) 2002; 221 Banzato (B322) 2008; 14 Okada (B214) 1992; 66 Goldberg (B256) 2005; 13 Sasaki (B180) 2004; 204 Laurent (B24) 1998 Lisignoli (B202) 2001; 44 Chen (B4) 2009; 284 Tashiro (B268) 2012; 2012 Cillero-Pastor (B137) 2011; 12 Balogh (B82) 2008; 56 Zhang (B125) 2015; 5 Migliore (B66) 2010; 20 Samuels (B101) 2008; 66 Fukuda (B172) 1996; 277 B39 Irwin (B245) 1980; 50 Tammi (B271) 1990; 35 Adams (B227) 1988 Fallacara (B9) 2017; 22 Holmberg (B303) 1984; 91 Yasui (B183) 1992; 37 Conrozier (B27) 2008; 9 Murphy (B113) 2009; 11 Wu (B313) 2015; 29 Wobig (B333) 1998; 20 Song (B117) 2017; 8 Kapoor (B116) 2011; 7 Balazs (B73) 1993; 39 Aya (B281) 2014; 22 Misra (B320) 2003; 278 Goto (B218) 1988; 92 Laurent (B88) 1991; 76 Eriksson (B90) 1983; 144 Gotoh (B78) 1993; 52 Yu (B2) 2008; 10 Pierce (B93) 2004 Fraser (B94) 1984; 11 Åsheim (B238) 1976; 17 Isacke (B49) 2002; 34 Song (B109) 2018; 9 Lee (B37) 2000; 12 Bolduc (B118) 2019; 132 Wang (B252) 2004 Hemming (B98) 2008; 18 Moreland (B14) 2003; 5 Listrat (B260) 1997; 5 Siczkowski (B200) 1993; 21 Choi (B145) 2015; 103 Rose (B239) 1979; 27 B50 Takahashi (B67) 1999; 7 B59 Laurent (B23) 1996; 74 Pozo (B187) 1997; 116 Svala (B115) 2017; 49 Bhattacharya (B56) 2017; 5 B102 Lokeshwar (B327) 2014; 123 Liu (B3) 2011; 10 B100 Albert (B335) 2006; 73 Pelletier (B213) 1989; 16 Loeser (B210) 2009; 17 Goto (B201) 1999; 187 Sugahara (B1) 1979; 254 Termeer (B70) 2003; 24 Karatosum (B263) 2005; 23 Meyers (B228) 1990; 33 Gingerich (B186) 1981; 30 Brandt (B334) 2001; 385 Strauss (B158) 2009; 37 Archer (B209) 2003; 35 Kaya (B278) 1997; 15 Gu (B120) 2016; 95 Rasheed (B121) 2016; 594 Fraser (B157) 1993; 22 Parashar (B316) 2018; 2018 Ghatak (B319) 2002; 277 Hu (B124) 2018; 94 Misra (B321) 2006; 281 Rydell (B76) 1971; 80 Finelli (B143) 2011; 48 B77 Marshall (B150) 2000; 12 Kim (B130) 2007; 8 Felson (B185) 2005; 17 Yang (B299) 2010; 13 McIlwraith (B161) 1997; 9 Picker (B276) 1989; 109 B129 Chen (B7) 1999; 7 B126 Jerosch (B155) 2011; 2011 De la Pina (B189) 2002; 99 Gupta (B44) 2019 Gocmen (B176) 2015; 43 Turino (B21) 2017; 153 McCourt (B31) 1999; 18 Yasuda (B60) 2009; 19 Lee (B294) 2017; 55 Waddell (B251) 2007; 24 Dechert (B26) 2006; 14 Chen (B325) 2018; 181 Yatabe (B193) 2009; 68 West (B280) 1985; 228 B85 Auer (B242) 1980; 41 Lees (B284) 1995; 73 Gao (B311) 2015; 6 Blanco (B127) 1995; 146 Ghosh (B223) 1993; 22 Weismann (B35) 1954; 76 Tanaka (B181) 2006; 26 Lepperdinger (B97) 1998; 273 Cope (B103) 2019; 27 Nonaka (B184) 2000; 27 Seto-Rogers (B326) 2012; 12 Takahashi (B198) 2000; 27 B257 Yoshimi (B194) 1994; 298 Wang (B277) 1992; 98 Stickeler (B308) 1997; 17 Necas (B16) 2008; 8 Eurlings (B19) 2014; 307 Gingerich (B243) 1979; 2 Lepetos (B119) 2019; 132 Selway (B240) 1985; 5 Takahashi (B65) 2001; 19 Grishko (B134) 2009; 284 Engström-Laurent (B91) 1990; 24 Cao (B203) 2005; 20 Balasz (B12) 1998 Gomis (B147) 2004; 50 Balazs (B163) 1982 Csoka (B40) 2013; 23 Mobasheri (B110) 2015; 80 Turley (B309) 2002; 27 Kim (B323) 2013; 34 Weiss (B160) 1995; 12 Myers (B226) 1987; 14 Gupta (B42) 2016 Miwa (B133) 2000; 8 B261 Orian-Rousseau (B317) 2015; 6 Kotevoglu (B169) 2006; 26 Toole (B36) 1997; 242 Losina (B105) 2013; 65 Maudens (B152) 2018; 23 Brun (B205) 2012; 100 Volpi (B61) 2009; 16 Fukuda (B174) 2001; 9 Balazs (B11) 1985; 5 Ludwig (B144) 2012; 64 Tikiz (B168) 2005; 24 Juni (B265) 2007; 56 Yudoh (B112) 2005; 7 Hsieh (B167) 2008; 26 Campo (B177) 2003; 5 Chang (B217) 2007; 120 Fraser (B87) 1988; 256 Cucchiarini (B108) 2016; 3 Tolg (B287) 2014; 9 Knudson (B54) 2004; 427 B159 Frisbie (B249) 2016; 77 Neuman (B275) 2015; 18 B273 Del Carlo (B138) 2002; 46 Maclennan (B5) 1956; 15 Ghosh (B224) 1993; 22 Philip (B165) 1989; 9 Benitez (B310) 2011; 71 Maulvi (B292) 2015; 26 Wang (B122) 2016; 39 Nelson (B190) 2015; 35 Kikuchi (B195) 1996; 4 Tamer (B64) 2013; 6 Weigel (B279) 1989 Huang (B170) 2010; 68 Ogston (B63) 1953; 119 Hayward (B314) 2016; 7 Taskiran (B216) 1994; 200 Laffleur (B301) 2015; 6 Frenkel (B38) 2014; 11 Wobig (B142) 1999; 21 Hashimoto (B135) 1997; 40 Marshall (B146) 2000; 18 Roach (B221) 2004; 9 Kuyinu (B230) 2016; 11 Bowman (B107) 2018; 7 Hamerman (B33) 1954; 37 Zaman (B53) 2005; 33 Murray (B104) 2012; 380 Altman (B332) 1998; 25 Fallacara (B10) 2018; 10 Lopez-Armada (B139) 2006; 14 Camillieri (B298) 2004; 20 Svanovsky (B89) 2008; 33 Williams (B291) 2013; 2013 Ghosh (B25) 2002; 32 Martin (B211) 2002; 3 Gaustad (B247) 1995; 27 Rydell (B71) 1970; 11 Hunter (B106) 2015; 372 Masuko (B178) 2009; 2 Chernos (B57) 2017; 7 Liang (B8) 2016; 97 B175 Ho (B300) 2013; 96 Reed (B95) 1990; 259 Yin (B123) 2017; 15 Pawlak (B188) 2000 Cake (B206) 2008; 13 Yang (B55) 2012; 287 Adams (B229) 1991; 18 Zhou (B199) 2009; 50 Breborowicz (B92) 2002 Smith (B191) 2013; 10 Ghosh (B13) 1994; 12 Hashizume (B15) 2010; 20 Pritchard (B253) 1999; 6 Studer (B111) 1999; 7 Blanco (B136) 2004; 4 Groβ (B20) 2017; 11 Aihara (B69) 1992; 100 Richardson (B248) 2007; 23 Presti (B171) 1994; 12 Toole (B306) 2008; 9 Frean (B197) 1999; 67 Tulamo (B164) 1994; 55 Dahiya (B18) 2013; 5 Lussier (B331) 1996; 23 Aubry-Rozier (B259) 2012; 14 Carapeba (B156) 2016; 2016 Ruth (B246) 1985; 7 Sanchez (B208) 2017; 25 Scanzello (B114) 2008; 20 Schiavinato (B236) 1989; 241 Liu (B84) 2003; 1 Meyers (B232) 1987; 14 Kim (B22) 2018; 10 Prehm (B6) 1990; 267 Weigel (B286) 1988; 10 Mattheolabakis (B312) 2015; 23 Juhlin (B32) 1997; 242 Asari (B148) 2010; 285 Hilbert (B162) 1984; 61 Adams (B166) 2000; 23 Niemelä (B244) 2016; 12 Lesley (B318) 2000; 275 Han (B329) 2016; 11 Rath (B290) 2011; 82 Laurent (B83) 1992; 6 Knott (B215) 1994; 21 Borzachhiello (B204) Gao (B274) 2010; 29 Entwistle (B52) 1996; 61 Borzachhiello (B74) 2010; 92 Wilson (B304) 1986; 17 Deckers (B231) 2019; 27 Bollyky (B285) 2012; 12 Fukuda (B173) 1997; 46 Jensen (B149) 2015; 18 Ström (B28) 2015; 132 Armstrong (B153) 1994; 21 Julovi (B192) 2011; 29 Rutjes (B269) 2012; 157 Fraser (B29) 1997; 242 McDevitt (B234) 1976; 58 Amiel (B219) 2003; 11 Lorenz (B141) 2006; 40 Stiebel-Kalish (B297) 1998; 12 Iannitti (B151) 2011; 11 Holmes (B41) 1988; 250 Berenbaum (B99) 2013; 21 Knudson (B80) 2018; 79 Shan (B222) 2004; 279 Lo (B254) 2004; 290 Pak (B237) 2016; 19 Miyake (B48) 1990; 172 Oe (B62) 2016; 15 Cyphert (B79) 2015; 2015 Karlsson (B262) 2002; 41 Galley (B241) 1986; 32 Meyer (B34) 1934; 107 Stern (B96) 2007; 25 Sattar (B282) 1994; 103 Fraser (B86) 1981; 200 Montagner (B307) 2015; 2 Aruffo (B47) 1990; 61 Negi (B328) 2015; 73 Wang (B315) 2017; 15 Koivusalo (B302) 2018; 85 Abate (B330) 2012 Jamil (B140) 2011; 14 Berenbaum (B250) 2012; 71 Sommarin (B45) 1983; 214 Vogel (B289) 2010; 149 Hwang (B131) 2015; 16 Peyron (B72) 1974; 22 Carney (B225) 1985; 3 Waddell (B68) 2007; 465 Mero (B324) 2014; 6 Shimizu (B196) 1998; 25 Palmoski (B212) 1976; 70 Charlier (B132) 2016; 17 Salwowska (B293) 2016; 15 Venable (B258) 2008; 69 Aviad (B81) 1993; 21 Mainil-Varlet (B220) 2013; 4 Punji (B179) 1989; 7 Stern (B30) 2004; 83 Savani (B46) 2001; 276 Balazs (B75) 1967; 10 Jiang (B17) 2011; 91 Abatangelo (B235) 1989; 241 Julovi (B51) 2004; 50 Weigel (B270) 1986; 11 Raman (B267) 2008; 15 |
References_xml | – volume: 7 start-page: R380 year: 2005 ident: B112 article-title: Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: Oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function publication-title: Arthr Res Ther doi: 10.1186/ar1499 – volume: 144 start-page: 223 year: 1983 ident: B90 article-title: Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver publication-title: Exp Cell Res doi: 10.1016/0014-4827(83)90458-5 – ident: B273 – volume: 290 start-page: 3115 year: 2004 ident: B254 article-title: Intra-articular hyaluronic acid in treatment of knee oateoarthritis: a meta-analysis publication-title: JAMA doi: 10.1001/jama.290.23.3115 – volume: 5 start-page: 8183 year: 2017 ident: B56 article-title: Impact of structurally modifying hyaluronic acid on CD44 interaction publication-title: J Mater Chem B doi: 10.1039/C7TB01895A – volume: 33 start-page: 149 year: 2008 ident: B89 article-title: The effect of molecular weight on the biodistribution of hyaluronic acid radiolabeled with 111In after intravenous administration to rats publication-title: Eur J Drug Metab Pharmacokinet doi: 10.1007/BF03191112 – volume: 15 start-page: 996 year: 1997 ident: B278 article-title: Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation publication-title: Genes Dev doi: 10.1101/gad.11.8.996 – volume: 13 start-page: 131 year: 2016 ident: B255 article-title: Hyaluronic acid in the management of osteoarthritis: injection therapies innovations publication-title: Clin Cases Miner Bone Metab doi: 10.11138/ccmbm/2016.13.2.131 – volume: 33 start-page: 1406 year: 1990 ident: B228 article-title: Synovitis and osteoarthritic changes in canine articular cartilage after anterior cruciate ligament transection: Effect of surgical homeostasis publication-title: Arthr Rheum doi: 10.1002/art.1780330913 – volume: 24 start-page: 112 year: 2003 ident: B70 article-title: Hyaluronan-magic glue for the regulation of the immune response? publication-title: Trends Immunol doi: 10.1016/S1471-4906(03)00029-2 – volume: 61 start-page: 569 year: 1996 ident: B52 article-title: HA receptors: regulators of signaling to the cytoskeleton publication-title: J Cell Biochem doi: 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B – volume: 279 start-page: 37939 year: 2004 ident: B222 article-title: A potential role of 15-deoxy. (12:14). prostaglandin J2 for induction of human articular chondrocyte apoptosis in arthritis publication-title: J Biol Chem doi: 10.1074/jbc.M402424200 – volume: 26 start-page: 475 year: 2008 ident: B167 article-title: Effects of different molecular weight hyaluronan products on the expression of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis publication-title: J Orthop Res doi: 10.1002/jor.20524 – volume: 107 start-page: 629 year: 1934 ident: B34 article-title: The polysaccharide of the vitreous humor publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)75338-6 – ident: B129 – volume: 15 start-page: 11 year: 2016 ident: B62 article-title: Oral hyaluronan relieves knee pain: a review publication-title: Nutr Res doi: 10.1186/s12937-016-0128-2 – volume: 35 start-page: 401 year: 2003 ident: B209 article-title: The chondrocyte publication-title: Int J Biochem Cell Biol doi: 10.1016/S1357-2725(02)00301-1 – start-page: 365 volume-title: Nutraceuticals in Veterinary Medicine. year: 2019 ident: B44 article-title: Nutraceuticals in arthritis doi: 10.1007/978-3-030-04624-8_24 – volume: 3 start-page: 140 year: 1985 ident: B225 article-title: Structure of newly synthesized. (35S)-proteoglycans and. (35S)-proteoglycan turnover products of cartilage explant cultures from dogs with experimental osteoarthritis publication-title: J Orthop Res doi: 10.1002/jor.1100030203 – volume: 46 start-page: 394 year: 2002 ident: B138 article-title: Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species publication-title: Arthr Rheumatol doi: 10.1002/art.10056 – volume: 18 start-page: 53 year: 2015 ident: B275 article-title: hyaluronic acid and wound healing publication-title: J Pharm Pharm Sci doi: 10.18433/J3K89D – volume: 17 start-page: 624 year: 2005 ident: B185 article-title: The sources of pain in knee osteoarthritis publication-title: Curr Opin Rheumatol doi: 10.1097/01.bor.0000172800.49120.97 – volume: 172 start-page: 69 year: 1990 ident: B48 article-title: Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition publication-title: J Exp Med doi: 10.1084/jem.172.1.69 – volume: 6 start-page: 111 year: 2013 ident: B64 article-title: Hyaluronan and synovial joint: function, distribution and healing publication-title: Interdiscipl Toxicol doi: 10.2478/intox-2013-0019 – ident: B175 – volume: 21 start-page: 126 year: 1993 ident: B200 article-title: Hyaluronic acid regulates the function and distribution of sulfated glycosaminoglycans in bone marrow stromal cultures publication-title: Exp Hematol – volume: 9 start-page: 249 year: 2008 ident: B306 article-title: Hyaluronan oligosaccharides as a potential anticancer therapeutic publication-title: Curr Pharm Biotechnol doi: 10.2174/138920108785161569 – volume: 372 start-page: 1040 year: 2015 ident: B106 article-title: Viscosupplementation for osteoarthritis of the knee publication-title: New Engl J Med doi: 10.1056/NEJMct1215534 – volume: 22 start-page: 18 year: 1993 ident: B223 article-title: The effects of intraarticular administration of hyaluronan in a model of early oateoarthritis in sheep. I. Gait analysis and radiological and morphological studies publication-title: Semin Arthr Rheum doi: 10.1016/S0049-0172(10)80016-2 – volume: 13 start-page: 216 year: 2005 ident: B256 article-title: Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity publication-title: Osteoarthr Cartil doi: 10.1016/j.joca.2004.11.010 – volume: 69 start-page: 1569 year: 2008 ident: B258 article-title: Examination of synovial fluid hyaluronan quantity and quality in stifle joints of dogs with osteoarthritis publication-title: Am J Vet Res doi: 10.2460/ajvr.69.12.1569 – volume: 7 start-page: 247 year: 1989 ident: B179 article-title: The influence of intra-articular hyaluronic acid on PGE2 and cAMP of synovial fluid publication-title: Clin Exp Rheumatol – volume: 29 start-page: 107 year: 2010 ident: B274 article-title: Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis publication-title: Matrix Biol doi: 10.1016/j.matbio.2009.11.002 – volume: 79 start-page: 32 year: 2018 ident: B80 article-title: The pericellular hyaluronan of articular chondrocytes publication-title: Matric Biol doi: 10.1016/j.matbio.2018.02.005 – volume: 7 start-page: 34158 year: 2016 ident: B314 article-title: Hyaluronic acid-conjugated liposome nanoparticles for targeted delivery to CD44 overexpressing glioblastoma cells publication-title: Oncotarget doi: 10.18632/oncotarget.8926 – volume: 47 start-page: 536 year: 1994 ident: B288 article-title: Hyaluronic acid: a review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing publication-title: Drugs doi: 10.2165/00003495-199447030-00009 – volume: 277 start-page: 38013 year: 2002 ident: B319 article-title: Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway publication-title: J Biol Chem doi: 10.1074/jbc.M202404200 – volume: 284 start-page: 9132 year: 2009 ident: B134 article-title: Effects of hyaluronic acid on mitochondrial function and mitochondria-driven apoptosis following oxidative stress in human chondrocytes publication-title: J Biol Chem doi: 10.1074/jbc.M804178200 – volume: 27 start-page: 5 year: 1979 ident: B239 article-title: The intra-articular use of sodium hyaluronate for the treatment of osteoarthrosis in the horse publication-title: NZ Vet J doi: 10.1080/00480169.1979.34585 – volume: 278 start-page: 25285 year: 2003 ident: B320 article-title: Regulation of multidrug resistance in cancer cells by hyaluronan publication-title: J Biol Chem doi: 10.1074/jbc.C300173200 – volume: 66 start-page: 244 year: 2008 ident: B101 article-title: Osteoarthritis: a tale of three tissues publication-title: Bull NYU Joint Dis – volume: 11 start-page: 219 year: 1986 ident: B270 article-title: A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing publication-title: J Theoret Biol doi: 10.1016/S0022-5193(86)80076-5 – volume: 12 start-page: 75 year: 1994 ident: B13 article-title: The role of hyaluronic acid. (hyaluronan) in health and disease: Interactions with cells, cartilage and components of synovial fluid publication-title: Clin Exp Rheumatol. – volume: 25 start-page: 2203 year: 1998 ident: B332 article-title: Intraarticular sodium hyaluronate. (Hyalgan®) in the treatment of patients with osteoarthritis of the knee: A randomized clinical trial publication-title: J Rheumatol – volume: 22 start-page: 9 year: 1993 ident: B157 article-title: The kinetics of hyaluronan in normal and acutely inflammed synovial joints: Exploratory observations with experimental arthritis in sheep publication-title: Semin Arthr Rheum doi: 10.1016/S0049-0172(10)80015-0 – volume: 32 start-page: 657 year: 1986 ident: B241 article-title: The use of hyaluronic acid in the racehorse publication-title: Proc Am Assoc Equine Pract – volume: 11 start-page: 17 year: 1984 ident: B94 article-title: Elimination of hyaluronic acid from the bloodstream in the human publication-title: Clin Exp Pharm Physiol doi: 10.1111/j.1440-1681.1984.tb00235.x – volume: 4 start-page: 715 year: 2004 ident: B136 article-title: Mitochondrial dysfunction in osteoarthritis publication-title: Mitochondrion doi: 10.1016/j.mito.2004.07.022 – start-page: 325 volume-title: The Chemistry, Biology, and Medical Applications of Hyaluronan and its Derivatives. year: 1998 ident: B12 article-title: New applications for hyaluronan – volume: 6 start-page: 2397 year: 1992 ident: B83 article-title: Hyaluronan publication-title: FASEB J doi: 10.1096/fasebj.6.7.1563592 – volume: 55 start-page: 710 year: 1994 ident: B164 article-title: Concentration and molecular weight distribution of hyaluronate in synovial fluid from clinically normal horses and horses with diseased joints publication-title: Am J Vet Res doi: 10.2460/ajvr.1994.55.05.710 – volume: 23 start-page: 1761 year: 2018 ident: B152 article-title: Recent advances in intra-articular drug delivery systems for oateoarthritis therapy publication-title: Drug Discov Today doi: 10.1016/j.drudis.2018.05.023 – volume: 132 start-page: 90 year: 2019 ident: B119 article-title: Redox and NF-κB signaling in osteoarthritis publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2018.09.025 – volume: 65 start-page: 703 year: 2013 ident: B105 article-title: Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US publication-title: Arthritis Care Res doi: 10.1002/acr.21898 – volume: 57 start-page: 1410 year: 2007 ident: B266 article-title: Hylan versus hyaluronic acid for osteoarthritis of the knee: A symptomatic review and meta-analysis publication-title: Arthr Rheum doi: 10.1002/art.23103 – volume: 2012 start-page: 167928 year: 2012 ident: B268 article-title: Oral administration of polymer hyaluronic acid alleviates symptoms of knee osteoarthritis: a double-blind, placebo-controlled study over a 12-month period publication-title: Scientif World J doi: 10.1100/2012/167928 – volume: 37 start-page: 1636 year: 2009 ident: B158 article-title: Hyaluronic acid viscosupplementation and osteoarthritis: current uses and future directions publication-title: Am J Sports Med doi: 10.1177/0363546508326984 – volume: 92 start-page: 17 year: 1988 ident: B218 article-title: Experimental knee pain model in rats and analgesic effect of sodium hyaluronate publication-title: Folia Pharmacol JPN doi: 10.1254/fpj.92.17 – volume: 187 start-page: 1 year: 1999 ident: B201 article-title: Hyaluronic acid suppresses the reduction of alpha2(VI). collagen gene expression caused by interleukin-1beta in cultured rabbit articular chondrocytes publication-title: Tohoku J Exp Med doi: 10.1620/tjem.187.1 – volume: 12 start-page: 829 year: 1998 ident: B297 article-title: A comparison of the effect of hyaluronic acid versus gentamicin on corneal epithelial healing publication-title: Eye. doi: 10.1038/eye.1998.213 – volume: 2013 start-page: 460435 year: 2013 ident: B291 article-title: A crosslinked HA-based hydrogel ameliorates dry eye symptoms in dogs publication-title: Int J Biomaterials. doi: 10.1155/2013/460437 – volume: 100 start-page: 359 year: 1992 ident: B69 article-title: Effects of sodium hyaluronate on the nociceptive response of rats with experimentally induced arthritis publication-title: Nippon Yakurigaku Zasshi doi: 10.1254/fpj.100.359 – volume: 5 start-page: 309 year: 2013 ident: B18 article-title: Hyaluronic acid: a boon in periodontal therapy publication-title: N Am J Med Sci doi: 10.4103/1947-2714.112473 – volume: 26 start-page: 185 year: 2006 ident: B181 article-title: Suppressive effects of hyaluronan on MMP-1 and RANTES production from chondrocytes publication-title: Rheumatol Int doi: 10.1007/s00296-004-0547-9 – volume: 267 start-page: 185 year: 1990 ident: B6 article-title: Release of hyaluronate from eukaryotic cells publication-title: Biochem J. doi: 10.1042/bj2670185 – volume: 242 start-page: 35 year: 1997 ident: B36 article-title: Hyaluronan in morphogenesis publication-title: J Intern Med doi: 10.1046/j.1365-2796.1997.00171.x – volume: 94 start-page: 79 year: 2018 ident: B124 article-title: MiR-26a and miR-26b mediate osteoarthritis progression by targeting FUT4 via NF-kappaB signaling pathway publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2017.12.003 – volume: 22 start-page: 731 year: 1974 ident: B72 article-title: Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joint publication-title: Pathol Biol – volume: 281 start-page: 34936 year: 2006 ident: B321 article-title: Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells publication-title: J Biol Chem doi: 10.1074/jbc.C600138200 – volume: 6 start-page: 1211 year: 2015 ident: B301 article-title: Development of novel mucoadhesive hyaluronic acid derivate as lubricant for the treatment of dry eye syndrome publication-title: Ther Deliv doi: 10.4155/tde.15.55 – volume: 66 start-page: 680 year: 1992 ident: B214 article-title: Localization of matrix metalloproteinase 3. (stromelysin) in osteoarthritic cartilage and synovium publication-title: Lab Invest – volume: 7 start-page: 17 year: 2017 ident: B57 article-title: Rheological study of hyaluronic acid derivatives publication-title: Biomed Eng Lett doi: 10.1007/s13534-017-0010-y – volume: 70 start-page: 87 year: 1976 ident: B212 article-title: Hyaluronate-binding by proteoglycans: comparison of mildly and severely osteoarthritic regions of human femoral cartilage publication-title: Clin Chim Acta doi: 10.1016/0009-8981(76)90008-5 – volume: 7 start-page: 33 year: 2011 ident: B116 article-title: Role of proinflammatory cytokines in the pathophysiology of osteoarthritis publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2010.196 – volume: 56 start-page: 3610 year: 2007 ident: B265 article-title: Efficacy and safety of intraarticular Hylan or hyaluronic acids for osteoarthritis of the knee. A randomized controlled trial publication-title: Arthr Rheum doi: 10.1002/art.23026 – volume: 10 start-page: 99 year: 2011 ident: B3 article-title: Microbial production of hyaluronic acid: current state, challenges and perspectives publication-title: Microb Cell Fact. doi: 10.1186/1475-2859-10-99 – volume: 68 start-page: 146 year: 2010 ident: B170 article-title: Effect of different molecular weight hyaluronans on osteoarthritis-related protein production in fibroblast-like synoviocytes from patients with tibia plateau fracture publication-title: J Trauma doi: 10.1097/TA.0b013e3181a92cf8 – volume: 5 start-page: 217 year: 1985 ident: B11 article-title: Sodium hyaluronate and joint function publication-title: JEVS. doi: 10.1016/S0737-0806(85)80102-7 – volume: 21 start-page: 462 year: 1994 ident: B215 article-title: Induction of cyclooxygenase by interleukin 1: comparative study between human synovial cells and chondrocytes publication-title: J Rheumatol – volume: 34 start-page: 2313 year: 1993 ident: B296 article-title: The effect of hyaluronic acid on corneal epithelial cell proliferation publication-title: Invest Ophthalmol Vis Sci – volume: 23 start-page: 1579 year: 1996 ident: B331 article-title: Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada publication-title: J Rheumatol – volume: 58 start-page: 94 year: 1976 ident: B234 article-title: Biochemical changes in the cartilage of the knee in experimental and natural osteoarthritis in the dog publication-title: J Bone Joint Surg Br doi: 10.1302/0301-620X.58B1.131804 – volume: 204 start-page: 99 year: 2004 ident: B180 article-title: Hayluronan inhibits the interleukin-1beta-induced expression of matrix metalloproteinase. (MMP)-1 and MMP-3 in human synovial cells publication-title: Tohoku J Exp Med doi: 10.1620/tjem.204.99 – volume: 15 start-page: 485 year: 1956 ident: B5 article-title: The production of capsules, hyaluronic acid and hyaluronidase to 25 strains of Group C Streptococci publication-title: J Gen Microbiol. doi: 10.1099/00221287-15-3-485 – volume: 277 start-page: 1672 year: 1996 ident: B172 article-title: Hyaluronic acid stimulates proteoglycan synthesis in bovine articular cartilage in the presence of interleukin-1 publication-title: J Pharmacol Exp Ther – volume: 2 start-page: 373 year: 2015 ident: B307 article-title: Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer publication-title: Oncoscience doi: 10.18632/oncoscience.150 – ident: B77 – volume: 200 start-page: 142 year: 1994 ident: B216 article-title: Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1 publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.1994.1426 – volume: 427 start-page: 152 year: 2004 ident: B54 article-title: Hyaluronan and CD44: modulators of chondrocyte metabolism publication-title: Clin Orthop Relat Res doi: 10.1097/01.blo.0000143804.26638.82 – volume: 23 start-page: 115 year: 2000 ident: B166 article-title: A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee publication-title: Drug Safety doi: 10.2165/00002018-200023020-00003 – volume: 73 start-page: 205 year: 2006 ident: B335 article-title: Septic knee arthritis after intra-articular hyaluronate injection: Two case reports publication-title: Joint Bone Spine doi: 10.1016/j.jbspin.2005.03.005 – ident: B39 – volume: 39 start-page: 3 year: 1993 ident: B73 article-title: Viscosupplementation: a new concept in the treatment of osteoarthritis publication-title: J Rheumatol. – volume: 50 start-page: 314 year: 2004 ident: B147 article-title: Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents publication-title: Arthr Rheum doi: 10.1002/art.11421 – volume: 8 start-page: 69351 year: 2017 ident: B117 article-title: HIF-1alpha: CRAT: miR-144-3p axis dysregulation promotes osteoarthritis chondrocytes apoptosis and VLCFA accumulation publication-title: Oncotarget doi: 10.18632/oncotarget.20615 – start-page: 248 volume-title: The Biology of Hyaluronan. Ciba Foundation Symposium 143. year: 1989 ident: B279 article-title: The specific interaction between fibrin(ogen). and hyaluronan: possible consequences in hemostasis, inflammation and wound healing – volume: 2011 start-page: 1 year: 2011 ident: B155 article-title: Effects of glucosamine and chondroitin sulfate on cartilage metabolism in OA: outlook on other nutrient partners especially omega-3 fatty acids publication-title: Int J Rheumatol doi: 10.1155/2011/969012 – volume: 385 start-page: 130 year: 2001 ident: B334 article-title: Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis publication-title: ORTHOVISC Study Group Clin Orthop doi: 10.1097/00003086-200104000-00021 – volume: 50 start-page: 832 year: 2009 ident: B199 article-title: The protective effect of sodium hyaluronate on the cartilage of rabbit osteoarthritis by inhibiting peroxisome proliferator-activated receptor-gamma messenger RNA expression publication-title: Yonsei Med J doi: 10.3349/ymj.2009.50.6.832 – volume: 23 start-page: 213 year: 2005 ident: B263 article-title: Comparison of two hyaluronan drugs in patients with advanced osteoarthritis of the knee: a prospective, randomized, double-blind study with long-term follow-up publication-title: Clin Exp Rheumatol – volume: 214 start-page: 777 year: 1983 ident: B45 article-title: Specific interaction between cartilage proteoglycans and hyaluronic acid at the chondrocyte cell surface publication-title: Biochem J doi: 10.1042/bj2140777 – volume: 6 start-page: 346 year: 2014 ident: B324 article-title: Hyaluronic acid bioconjugates for the delivery of bioactive molecules publication-title: Polymers doi: 10.3390/polym6020346 – volume: 20 start-page: 55 year: 2010 ident: B66 article-title: Hylan g-f 20: review of its safety and efficacy in the management of joint pain in osteoarthritis publication-title: Clin Med Insights Arthr Musculoskelet Disord doi: 10.1177/117954411000300001 – volume: 2 start-page: 291 year: 1979 ident: B243 article-title: Force plate studies on the effect of exogenous hyaluronic acid on joint function in equine arthritis publication-title: J Vet Pharmacol Ther doi: 10.1111/j.1365-2885.1979.tb00403.x – start-page: 453 volume-title: Hyaluronan, Vol 2. Biomedical, Medical and Clinical Aspects. year: 2002 ident: B92 article-title: Effects of hyaluronan used as a supplement in peritoneal dialysis solutions – volume: 21 start-page: 1549 year: 1999 ident: B142 article-title: The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of Hyalgan G-F 20 and a lower-molecular weight hyaluronan publication-title: Clin Ther doi: 10.1016/S0149-2918(00)80010-7 – volume: 43 start-page: 125 year: 1995 ident: B272 article-title: Expression of proteoglycans and hyaluronan during wound healing publication-title: J Histochem Cytochem doi: 10.1177/43.2.7529785 – volume: 16 start-page: 26035 year: 2015 ident: B131 article-title: Chondrocyte apoptosis in the pathogenesis of osteoarthritis publication-title: Int J Mol Sci doi: 10.3390/ijms161125943 – start-page: 101 volume-title: Osteoarthritis-Diagnosis, Treatment and Surgery. year: 2012 ident: B330 article-title: Hyaluronic acid in the treatment of osteoarthritis: what is new doi: 10.5772/26818 – volume: 9 start-page: 296 year: 1997 ident: B161 article-title: Use of sodium hyaluronate. (Hyaluronan) in equine joint disease publication-title: Equine Vet Educ doi: 10.1111/j.2042-3292.1997.tb01747.x – volume: 181 start-page: 150 year: 2018 ident: B325 article-title: Conjugation of paclitaxel to C-6 hexanediamine-modified hyaluronic acid for targeted drug delivery to enhance antitumor efficacy publication-title: Carbohydr Polym doi: 10.1016/j.carbpol.2017.09.017 – volume: 27 start-page: 356 year: 1995 ident: B247 article-title: Comparison of polysulfated glycosaminoglycan and sodium hyaluronate with placebo in treatment of traumatic arthritis in horses publication-title: Equine Vet J doi: 10.1111/j.2042-3306.1995.tb04070.x – volume: 12 start-page: 497 year: 1995 ident: B160 article-title: Musculoskeletal applications of hyaluronan and hylan. Potential uses in the foot and ankle publication-title: Clin Podiatr Med Surg doi: 10.1016/S0891-8422(23)00955-2 – volume: 17 start-page: 971 year: 2009 ident: B210 article-title: Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix publication-title: Osteoarthr Cartil doi: 10.1016/j.joca.2009.03.002 – volume: 95 start-page: e4315 year: 2016 ident: B120 article-title: MicroRNA-9 regulates the development of knee osteoarthritis through the NF-kappaB1 pathway in chondrocytes publication-title: Medicine doi: 10.1097/MD.0000000000004315 – volume: 2 start-page: 77 year: 2009 ident: B178 article-title: Anti-inflammatory effects of hyaluronan in arthritis therapy: not just for viscosity publication-title: Int J Med doi: 10.2147/IJGM.S5495 – volume: 153 start-page: 792 year: 2017 ident: B21 article-title: The therapeutic potential of hyaluronan in COPD publication-title: Chest doi: 10.1016/j.chest.2017.12.016 – volume: 71 start-page: 4085 year: 2011 ident: B310 article-title: Targeting hyaluronidase for cancer therapy: antitumor activity of sulfated hyaluronic acid in prostate cancer cells publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-10-4610 – volume: 1 start-page: 67 year: 2003 ident: B84 article-title: Metabolism of macromolecules in tissue publication-title: Lymphat Res Biol doi: 10.1089/15396850360495718 – volume: 7 start-page: 182 year: 1999 ident: B67 article-title: The effect of hyaluronan on matrix metalloproteinase-3. (MMP-3), interleukin-1beta. (IL-1beta), and tissue inhibitor of metalloproteinase-1. (TIMP-1). gene expression during the development of osteoarthritis publication-title: Osteoarthr Cartil doi: 10.1053/joca.1998.0207 – volume: 5 start-page: R122 year: 2003 ident: B177 article-title: Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats publication-title: Arthr Res Ther doi: 10.1186/ar748 – start-page: 538 year: 2004 ident: B252 article-title: Therapeutic effects of hyaluronic acid on osteoarthritis of the knee: A meta-analysis of randomized controlled trials publication-title: J Bone Joint Surg Am doi: 10.2106/00004623-200403000-00012 – ident: B100 – volume: 34 start-page: 8478 year: 2013 ident: B323 article-title: Bioimaging and pulmonary applications of self-assembled Flt1 peptide-hyaluronic acid conjugate nanoparticles publication-title: Biomaterials doi: 10.1016/j.biomaterials.2013.07.062 – volume: 56 start-page: 10582 year: 2008 ident: B82 article-title: Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs publication-title: J Agr Food Chem doi: 10.1021/jf8017029 – volume: 16 start-page: 19 year: 1989 ident: B213 article-title: Evidence for the involvement of interleukin-1 in human osteoarthritic cartilage degradation. Protective effects of NSAIDS publication-title: J Rheumatol doi: 10.1016/0049-0172(89)90080-2 – volume: 11 start-page: 159 year: 2014 ident: B38 article-title: The role of hyaluronan in wound healing publication-title: Int Wound J doi: 10.1111/j.1742-481X.2012.01057.x – volume: 61 start-page: 1303 year: 1990 ident: B47 article-title: CD44 is the principal cell surface receptor for hyaluronate publication-title: Cell doi: 10.1016/0092-8674(90)90694-A – volume: 71 start-page: 1454 year: 2012 ident: B250 article-title: A randomized, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2011-200972 – volume: 12 start-page: 281 year: 1994 ident: B171 article-title: Hyaluronan mediated protective effect against cell damage caused by enzymatically produced hydroxyl. (OH·) radicals is dependent on hyaluronan molecular mass publication-title: Cell Biochem Funct doi: 10.1002/cbf.290120409 – volume: 76 start-page: 1753 year: 1954 ident: B35 article-title: The structure of hyaluronic acid and of hyaluronic acid from umbilical cord publication-title: J Am Chem Soc doi: 10.1021/ja01636a010 – volume: 18 start-page: 95 year: 2015 ident: B149 article-title: Oral intake of a liquid-high-molecular-weight hyaluronan associated with relief of chronic pain and reduced use of pain medication: results of a randomized, placebo-controlled double-blind pilot study publication-title: J Med Food doi: 10.1089/jmf.2013.0174 – volume: 13 start-page: 144 year: 2010 ident: B299 article-title: A crosslinked hyaluronan gel accelerates healing of corneal epithelial abrasion and alkali burn injuries in rabbits publication-title: Vet Ophthalmol doi: 10.1111/j.1463-5224.2010.00771.x – volume: 9 start-page: 390 year: 2001 ident: B174 article-title: Sodium hyaluronate inhibits interleukin-1-evoked reactive oxygen species of bovine articular chondrocytes publication-title: Osteoarthr Cartil doi: 10.1053/joca.2000.0400 – volume: 116 start-page: 3 year: 1997 ident: B187 article-title: Reduction of sensory response to passive movements of inflamed knee joints by hylan, a hyaluronan derivative publication-title: Exp Brain Res doi: 10.1007/PL00005742 – volume: 259 start-page: 532 year: 1990 ident: B95 article-title: Removal rate of [3H] hyaluronan injected subcutaneously in rabbits publication-title: Am J Physiol. doi: 10.1152/ajpheart.1990.259.2.H532 – volume: 25 start-page: 1813 year: 1998 ident: B196 article-title: Histomorphometric and biochemical effect of various hyaluronans on early osteoarthritis publication-title: J Rheumatol – start-page: 1 volume-title: Hyaluronan 2003 Proceedings. Chapter 6. Musculoskeletal System. year: 2004 ident: B93 article-title: Efficacy of orally administered sodium hyaluronate gel in the racing thoroughbred – volume: 12 start-page: 581 year: 2000 ident: B37 article-title: Hyaluronan: a multifunctional, mega-Dalton, stealth molecule publication-title: Curr Opin Cell Biol doi: 10.1016/S0955-0674(00)00135-6 – volume: 91 start-page: 45 year: 1984 ident: B303 article-title: Sodium hyaluronate in cataract surgery: I. Report on the use of Healon® in two different types of intracapsular cataract surgery publication-title: Ophthalmology doi: 10.1016/S0161-6420(84)34341-X – volume: 132 start-page: 42194 year: 2015 ident: B28 article-title: Preparation and physical properties of hyaluronic acid-based cryogels publication-title: J Appl Polym Sci doi: 10.1002/app.42194 – volume: 2015 start-page: 563818 year: 2015 ident: B79 article-title: Size matters: molecular weight specificity of hyaluronan effects in cell biology publication-title: Int J Cell Biol doi: 10.1155/2015/563818 – ident: B261 – volume: 34 start-page: 718 year: 2002 ident: B49 article-title: The hyaluronan receptor, CD44 publication-title: Int J Biochem Cell Biol doi: 10.1016/S1357-2725(01)00166-2 – volume: 50 start-page: 516 year: 2004 ident: B51 article-title: Inhibition of interleukin-1beta-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage publication-title: Arthr Rheum doi: 10.1002/art.20004 – volume: 64 start-page: 3963 year: 2012 ident: B144 article-title: Diminished cartilage-lubricating ability of human osteoarthritic synovial fluid deficient in proteoglycan 4: Restoration through proteoglycan 4 supplementation publication-title: Arthr Rheum doi: 10.1002/art.34674 – volume: 9 start-page: e88479 year: 2014 ident: B287 article-title: Specific sizes of hyaluronan oligosaccharides stimulate fibroblast migration and excisional wound repair publication-title: Plos ONE. doi: 10.1371/journal.pone.0088479 – volume: 123 start-page: 35 year: 2014 ident: B327 article-title: Targeting hyaluronic acid family for cancer chemoprevention and therapy publication-title: Adv Cancer Res doi: 10.1016/B978-0-12-800092-2.00002-2 – volume: 3 start-page: 22 year: 2016 ident: B108 article-title: Basic science of osteoarthritis publication-title: J Exp Orthop doi: 10.1186/s40634-016-0060-6 – volume: 7 start-page: 25 year: 1985 ident: B246 article-title: Comparison of the effectiveness of intra-articular hyaluronic acid and conventional therapy for the treatment of naturally occurring arthritic conditions in equine publication-title: Equine Pract – volume: 50 start-page: 231 year: 1980 ident: B245 article-title: Sodium hyaluronate in equine traumatic arthritis publication-title: J South Afr Vet Assoc – volume: 7 start-page: 79 year: 1999 ident: B7 article-title: Functions of hyaluronan in wound repair publication-title: Wound Rep Reg. doi: 10.1046/j.1524-475X.1999.00079.x – volume: 18 start-page: 280 year: 2008 ident: B98 article-title: Mouse HYAL3 it encodes a 45-56-kDa glycoprotein overexpression increases whose hyaluronidase 1 activity in cultured cells publication-title: Glycobiology doi: 10.1093/glycob/cwn006 – volume: 15 start-page: 318 year: 2008 ident: B267 article-title: Efficacy of Hylan G-F20 and sodium hyaluronate in the treatment of osteoarthritis of the knee. A prospective randomized clinical trial publication-title: Knee doi: 10.1016/j.knee.2008.02.012 – volume: 103 start-page: 3072 year: 2015 ident: B145 article-title: Modulation of biomechanical properties of hyaluronic acid hydrogels by crosslinking agents publication-title: J Biomed Mater Res A. doi: 10.1002/jbm.a.35437 – volume: 46 start-page: 114 year: 1997 ident: B173 article-title: Hyaluronic acid inhibits interleukin-1-induced superoxide anion in bovine chondrocytes publication-title: Inflamm Res doi: 10.1007/s000110050132 – volume: 11 start-page: 213 year: 2009 ident: B113 article-title: HIF-mediated articular chondrocyte function: Prospects for cartilage repair publication-title: Arthr res Ther doi: 10.1186/ar2574 – volume: 74 start-page: A1 year: 1996 ident: B23 article-title: The structure and function of hyaluronan: an overview publication-title: Immun Cell Biol doi: 10.1038/icb.1996.32 – volume: 9 start-page: 265 year: 2004 ident: B221 article-title: Chondroptosis: a variant of apoptotic cell death in chondrocytes? publication-title: Apoptosis doi: 10.1023/B:APPT.0000025803.17498.26 – volume: 3 start-page: 257 year: 2002 ident: B211 article-title: Aging, articular cartilage chondrocyte senescence and osteoarthritis publication-title: Biogerontology doi: 10.1023/A:1020185404126 – volume: 465 start-page: 241 year: 2007 ident: B68 article-title: Hyaluronan suppresses IL-1beta-induced metalloproteinase activity from synovial tissue publication-title: Clin Orthop Relat Res doi: 10.1097/BLO.0b013e31815873f9 – volume: 285 start-page: 24751 year: 2010 ident: B148 article-title: Oral administration of high molecular weight hyaluronan. (900 kDa). controls immune system via Toll-like receptor 4 in the intestinal epithelium publication-title: J Biol Chem doi: 10.1074/jbc.M110.104950 – volume: 26 start-page: 1035 year: 2015 ident: B292 article-title: Extended release of hyaluronic acid from hydrogel contact lenses for dry eye syndrome publication-title: J Biomater Sci Polym Ed doi: 10.1080/09205063.2015.1072902 – volume: 37 start-page: 155 year: 1992 ident: B183 article-title: The effect of hyaluronan on interleukin-1-α-induced prostaglandin-E2 production in human osteoarthritic synovial cells publication-title: Agents Actions doi: 10.1007/BF01987905 – volume-title: Hyaluronan 2000 year: 2000 ident: B188 article-title: Mechanoprotective actions of elastoviscous hyalans on articular pain receptors – volume: 57 start-page: 637 year: 1998 ident: B58 article-title: Intra-articular hyaluronan treatment for osteoarthritis publication-title: Ann Rheum Dis doi: 10.1136/ard.57.11.637 – volume: 20 start-page: 565 year: 2008 ident: B114 article-title: Innate immune system activation in osteoarthritis: Is osteoarthritis a chronic wound? publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0b013e32830aba34 – volume: 20 start-page: 548 year: 2004 ident: B298 article-title: Hyaluronan-induced stimulation of corneal wound healing is a pure pharmacological effect publication-title: J Ocul Pharmacol Ther doi: 10.1089/1080768042727873 – ident: B50 – volume: 10 start-page: 701 year: 2018 ident: B10 article-title: Hyaluronic acid in the Third Millennium publication-title: Polymers doi: 10.3390/polym10070701 – volume: 18 start-page: 416 year: 2000 ident: B146 article-title: Amelioration of disease severity by intraarticular hylan therapy in bilateral canine osteoarthritis publication-title: J Orthop Res doi: 10.1002/jor.1100180313 – volume: 19 start-page: 1196 year: 2016 ident: B237 article-title: FlexPro, M. D, a mixture of krill oil, astaxanthin, hyaluronic acid, suppresses lipopolysaccharide-induced inflammatory cytokine production though inhibition of NF-κB publication-title: J Med Food doi: 10.1089/jmf.2016.3787 – volume: 276 start-page: 36770 year: 2001 ident: B46 article-title: Differential involvement of the hyaluronan. (HA). receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis publication-title: J Biol Chem doi: 10.1074/jbc.M102273200 – volume: 23 start-page: 605 year: 2015 ident: B312 article-title: Hyaluronic acid targeting of CD44 for cancer therapy: From receptor biology to nanomedicine publication-title: J Drug Target doi: 10.3109/1061186X.2015.1052072 – volume: 13 start-page: 514 year: 2008 ident: B206 article-title: Changes in gait after bilateral meniscectomy in sheep: Effect of two hyaluronan preparations publication-title: J Orthop Sci doi: 10.1007/s00776-008-1279-6 – volume: 11 start-page: 139 year: 1970 ident: B71 article-title: Hyaluronic acid in synovial fluid. VI Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of arthritis in track horses publication-title: Acta Vet Scand doi: 10.1186/BF03547976 – volume: 120 start-page: 166 year: 2007 ident: B217 article-title: Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4 publication-title: J Cell Sci doi: 10.1242/jcs.03310 – volume: 6 start-page: 197 year: 1999 ident: B253 article-title: A retrospective comparison of the efficacy and tolerability of sodium hyaluronate and hylan G-F 20 in the treatment of osteoarthritis of the knee publication-title: J Musculoskel Res doi: 10.1142/S021895770200085X – volume: 27 start-page: 997 year: 2000 ident: B184 article-title: Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis publication-title: J Rheumatol Suppl – volume: 21 start-page: 297 year: 1993 ident: B81 article-title: The molecular weight of therapeutic hyaluronan. (sodium hyaluronate): How significant it is? publication-title: J Rheumatol – volume: 157 start-page: 180 year: 2012 ident: B269 article-title: Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis publication-title: Ann Intern Med. doi: 10.7326/0003-4819-157-3-201208070-00473 – volume: 11 start-page: 13 year: 2011 ident: B151 article-title: Intra-articular injections for the treatment of osteoarthritis publication-title: Drug RD. doi: 10.1007/BF03259791 – volume: 68 start-page: 1051 year: 2009 ident: B193 article-title: Hyaluronan inhibits expression of ADAMTS4. (aggrecanase-1). in human osteoarthritic chondrocytes publication-title: Ann Rheum Dis doi: 10.1136/ard.2007.086884 – volume: 9 start-page: 1797 year: 2008 ident: B27 article-title: Long-term experience with hylan GF-20 in the treatment of knee osteoarthritis publication-title: Expert Opin Pharmacother doi: 10.1517/14656566.9.10.1797 – volume: 12 start-page: 42 year: 2011 ident: B137 article-title: Effect of nitric oxide on mitochondrial activity of human synovial cells publication-title: BMC Musculoskelet Disord doi: 10.1186/1471-2474-12-42 – volume: 19 start-page: 500 year: 2001 ident: B65 article-title: Hyaluronan suppressed nitric oxide production in the meniscus and synovium of rabbit osteoarthritis model publication-title: J Orthop Res doi: 10.1016/S0736-0266(00)90024-X – volume: 100 start-page: 2073 year: 2012 ident: B205 article-title: in vitro response of osteoarthritic chondrocytes and fibroblast-like synoviocytes to a 500-730 kDa hyaluronan amide derivative publication-title: J Biomed Mater Res B Appl Biomater doi: 10.1002/jbm.b.32771 – volume: 14 start-page: 252 year: 2006 ident: B26 article-title: Hyaluronan in human acute and chronic dermal wounds publication-title: Wound Rep Regener doi: 10.1111/j.1743-6109.2006.00119.x – ident: B126 – ident: B204 article-title: Evaluation of a novel hyaluronic acid derivative on synovial fluid viscoelastic properties publication-title: Biomaterials: European Conference on 2002:19 – volume: 10 start-page: 357 year: 1967 ident: B75 article-title: Hyaluronic acid in synovial fluid. I Molecular parameters of hyaluronic acid in normal and arthritic human fluids publication-title: Arthr Rheum doi: 10.1002/art.1780100407 – volume: 119 start-page: 244 year: 1953 ident: B63 article-title: The physiological function of hyaluronic acid in synovial fluid; viscous, elastic, and lubricant properties publication-title: J Physiol doi: 10.1113/jphysiol.1953.sp004842 – volume: 6 start-page: 154 year: 2015 ident: B317 article-title: CD44 acts as a signaling platform controlling tumor progression and metastasis publication-title: Front Immunol doi: 10.3389/fimmu.2015.00154 – volume: 21 start-page: 680 year: 1994 ident: B153 article-title: The effect of intra-articular hyaluronan on cartilage and subchondral bone changes in an ovine model of early osteoarthritis publication-title: J Rheumatol – volume: 14 start-page: 3598 year: 2008 ident: B322 article-title: A paclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords in vivo therapeutic activity publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-07-2019 – volume: 15 start-page: 551 year: 2017 ident: B123 article-title: Reduced miR26a and miR26b expression contributes to the pathogenesis of osteoarthritis via the production of p65 translocation publication-title: Mol Med Rep doi: 10.3892/mmr.2016.6035 – volume: 284 start-page: 18007 year: 2009 ident: B4 article-title: Hyaluronan molecular weight is controlled by UDP-N-acetylglucosamine concentration in Streptococcus zooepidemicus publication-title: J Biol Chem. doi: 10.1074/jbc.M109.011999 – volume: 33 start-page: 447 year: 2005 ident: B53 article-title: Expression and role of the hyaluronan receptor RHAMM in inflammation after bleomycin injury publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2004-0333OC – volume: 35 start-page: 219 year: 1990 ident: B271 article-title: Histochemical localization of hyaluronate in human oral epithelium using a specific hyaluronate-binding probe publication-title: Arch Oral Biol doi: 10.1016/0003-9969(90)90058-I – volume: 29 start-page: 1290 year: 2015 ident: B313 article-title: A novel role of low molecular weight hyaluronan in breast cancer metastasis publication-title: FASEB J doi: 10.1096/fj.14-259978 – volume: 298 start-page: 296 year: 1994 ident: B194 article-title: Effects of high-molecular-weight sodium hyaluronate on experimental osteoarthrosis induced by the resection of rabbit anterior cruciate ligament publication-title: Clin Orthop Rel Res doi: 10.1097/00003086-199401000-00039 – volume: 307 start-page: L557 year: 2014 ident: B19 article-title: A comparative study of matrix remodeling in chronic models for COPD; mechanistic insights into the role of TNF-alpha publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00116.2014 – ident: B85 – volume: 48 start-page: 263 year: 2011 ident: B143 article-title: A new viscosupplement based on partially hydrophobic hyaluronic acid: a comparative study publication-title: Biorheology doi: 10.3233/BIR-2011-0596 – volume: 8 start-page: 333 year: 2007 ident: B130 article-title: Cell death and apoptosis in osteoarthritic cartilage publication-title: Curr Drug Targets doi: 10.2174/138945007779940025 – volume: 17 start-page: 2146 year: 2016 ident: B132 article-title: Insights on molecular mechanisms of chondrocytes death in osteoarthritis publication-title: Int J Mol Sci doi: 10.3390/ijms17122146 – volume-title: The Chemistry, Biology and Medical Applications of Hyaluronan and Its Derivatives year: 1998 ident: B24 – volume: 80 start-page: 25 year: 1971 ident: B76 article-title: Effect of intraarticular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation publication-title: Clin Orthop Rel Res doi: 10.1097/00003086-197110000-00006 – volume: 11 start-page: 19 year: 2016 ident: B230 article-title: Animal models of osteoarthritis: Classification, update, and measurement of outcomes publication-title: J Orthop Surg Res doi: 10.1186/s13018-016-0346-5 – volume: 20 start-page: 410 year: 1998 ident: B333 article-title: Viscosupplementation with hylan G-F-20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee publication-title: Clin Ther doi: 10.1016/S0149-2918(98)80052-0 – volume: 29 start-page: 258 year: 2011 ident: B192 article-title: Hyaluronan inhibits matrix metalloproteinase-13 in human arthritic chondrocytes via CD44 and p38 publication-title: J Orthop Res doi: 10.1002/jor.21216 – volume: 85 start-page: 68 year: 2018 ident: B302 article-title: Hydrazone cross-linked hyaluronan-based hydrogels for therapeutic delivery of adipose stem cells to treat corneal defects publication-title: Mater Sci Eng C Mater Biol Appl doi: 10.1016/j.msec.2017.12.013 – volume: 132 start-page: 73 year: 2019 ident: B118 article-title: Reactive oxygen species, aging and articular cartilage homeostasis publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2018.08.038 – volume: 80 start-page: 237 year: 2015 ident: B110 article-title: Chondrosenescence: definition, hallmarks and potential role in the pathogenesis of osteoarthritis publication-title: Maturitas doi: 10.1016/j.maturitas.2014.12.003 – volume: 22 start-page: 31 year: 1993 ident: B224 article-title: The effects of intraarticular administration of hyaluronan in a model of early oateoarthritis in sheep. II. Cartilage composition and proteoglycan metabolism publication-title: Semin Arthr Rheum doi: 10.1016/S0049-0172(10)80017-4 – volume: 228 start-page: 1324 year: 1985 ident: B280 article-title: Angiogenesis induced by degradation products of hyaluronic acid publication-title: Science doi: 10.1126/science.2408340 – volume: 11 start-page: 631 year: 2017 ident: B20 article-title: Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjuctivitis publication-title: Clin Opthalmol. doi: 10.2147/OPTH.S131384 – volume: 26 start-page: 325 year: 2006 ident: B169 article-title: A prospective randomized controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis publication-title: Rheumatol Int doi: 10.1007/s00296-005-0611-0 – volume: 241 start-page: 278 year: 1989 ident: B235 article-title: Intra-articular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. I Biochemical results publication-title: Clin Orthop Relat Res doi: 10.1097/00003086-198904000-00037 – volume: 10 start-page: 355 year: 1988 ident: B286 article-title: The role of hyaluronic acid in inflammation and wound healing publication-title: Int J Tiss React – volume: 7 start-page: 377 year: 1999 ident: B111 article-title: Nitric oxide in osteoarthritis publication-title: Osteoarthr Cartil doi: 10.1053/joca.1998.0216 – volume: 221 start-page: 944 year: 2002 ident: B154 article-title: Mechanisms of action and potential uses of hyaluronan in dogs with osteoarthritis publication-title: J Am Vet Med Assoc doi: 10.2460/javma.2002.221.944 – volume: 91 start-page: 221 year: 2011 ident: B17 article-title: Hyaluronan as an immune regulator in human diseases publication-title: Physiol Rev doi: 10.1152/physrev.00052.2009 – volume: 18 start-page: 427 year: 1999 ident: B31 article-title: How does the hyaluronan scrap-yard operate? publication-title: Matrix Biol doi: 10.1016/S0945-053X(99)00045-1 – volume: 12 start-page: 471 year: 2012 ident: B285 article-title: The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation publication-title: Curr Diab Rep doi: 10.1007/s11892-012-0297-0 – volume: 10 start-page: 24 year: 2008 ident: B2 article-title: Metabolic engineering of Escherichia coli for biosynthesis of hyaluronic acid publication-title: Metab Eng. doi: 10.1016/j.ymben.2007.09.001 – volume: 35 start-page: 43 year: 2015 ident: B190 article-title: The effects of an oral preparation containing hyaluronic acid. (Oralvisc®) on obese knee osteoarthritis patients determined by pain, function, bradykinin, leptin, inflammatory cytokines, and heavy water analysis publication-title: Rheumatol Int doi: 10.1007/s00296-014-3047-6 – volume: 275 start-page: 26967 year: 2000 ident: B318 article-title: Hyaluronan binding by cell surface CD44 publication-title: J Biol Chem doi: 10.1074/jbc.M002527200 – start-page: 929 volume-title: Biomarkers in Toxicology, 2nd edn. year: 2019 ident: B43 article-title: Osteoarthritis biomarkers doi: 10.1016/B978-0-12-814655-2.00052-9 – start-page: 265 volume-title: Handbook of Models of Arthritis Research. year: 1988 ident: B227 article-title: The canine anterior cruciate ligament transection model of osteoarthritis – volume: 25 start-page: 537 year: 2007 ident: B96 article-title: The many ways to cleave hyaluronan publication-title: Biotechnol Adv doi: 10.1016/j.biotechadv.2007.07.001 – volume: 21 start-page: 16 year: 2013 ident: B99 article-title: Osteoarthritis as an inflammatory disease. (osteoarthritis is not osteoarthrosis!) publication-title: Osteoarthr Cartil doi: 10.1016/j.joca.2012.11.012 – volume: 11 start-page: 1413 year: 2016 ident: B329 article-title: Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells publication-title: Int J Nanomed doi: 10.2147/IJN.S95850 – volume: 256 start-page: 153 year: 1988 ident: B87 article-title: Uptake of hyaluronan in lymphatic tissue publication-title: Biochem J doi: 10.1042/bj2560153 – volume: 149 start-page: 594 year: 2010 ident: B289 article-title: Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution. (vismed, rejena) publication-title: Am J Ophthamol doi: 10.1016/j.ajo.2009.09.023 – volume: 20 start-page: 30 year: 2005 ident: B203 article-title: Hayluronan increases RANKL expression in bone marrow stromal cells through CD44 publication-title: J Bone Miner Res doi: 10.1359/jbmr.2005.20.1.30 – volume: 9 start-page: 39 year: 1989 ident: B165 article-title: Clinical trial comparison of intra-articular sodium hyaluronan products in horses publication-title: J Equine Vet Sci doi: 10.1016/S0737-0806(89)80120-0 – volume: 7 start-page: 6 year: 2018 ident: B107 article-title: Recent advances in hyaluronic acid based therapy for osteoarthritis publication-title: Clin Trans Med doi: 10.1186/s40169-017-0180-3 – volume: 37 start-page: 57 year: 1954 ident: B33 article-title: Hyaluronate in normal human synovial fluid publication-title: J Clin Invest doi: 10.1172/JCI103585 – volume: 242 start-page: 61 year: 1997 ident: B32 article-title: Hyaluronan in skin publication-title: J Intern Med doi: 10.1046/j.1365-2796.1997.00175.x – volume: 98 start-page: 105 year: 1992 ident: B277 article-title: Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages publication-title: Histochemistry doi: 10.1007/BF00717001 – volume: 40 start-page: 135 year: 2006 ident: B141 article-title: Osteoarthritis: cellular and molecular changes in degenerating cartilage publication-title: Prog Histochem Cytochem doi: 10.1016/j.proghi.2006.02.003 – volume: 2016 start-page: 20726921 year: 2016 ident: B156 article-title: Intra-articular hyaluronic acid compared to traditional conservative treatment in dogs with osteoarthritis associated with hip dysplasia publication-title: Evid-Based Compl Altern Med doi: 10.1155/2016/2076921 – volume: 24 start-page: 629 year: 2007 ident: B251 article-title: Viscosupplementation with hyaluronans for osteoarthritis of the knee. Clinical efficacy and economic implications publication-title: Drugs Aging doi: 10.2165/00002512-200724080-00002 – volume: 19 start-page: 644 year: 2009 ident: B60 article-title: Progress of research in osteoarthritis: pharmacological effects of hyaluronan publication-title: Clin Calcium – volume: 273 start-page: 22466 year: 1998 ident: B97 article-title: HYAL2, and the human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity publication-title: J Biol Chem doi: 10.1074/jbc.273.35.22466 – volume: 241 start-page: 286 year: 1989 ident: B236 article-title: Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. II Morphological findings publication-title: Clin Orthop Relat Res doi: 10.1097/00003086-198904000-00038 – volume: 43 start-page: 7 year: 2015 ident: B176 article-title: The antioxidant and anti-inflammatory efficiency of hyaluronic acid after third molar extraction publication-title: J Cranio-Maxillofac Surg doi: 10.1016/j.jcms.2015.04.022 – volume: 20 start-page: 432 year: 2010 ident: B15 article-title: High molecular weight hyaluronic acid relieved joint pain and prevented the progression of cartilage degeneration in a rabbit osteoarthritis model after onset of arthritis publication-title: Mol Rheumatol doi: 10.1007/s10165-010-0299-1 – volume: 27 start-page: 4589 year: 2002 ident: B309 article-title: Signaling properties of hyaluronan receptors publication-title: J Biol Chem doi: 10.1074/jbc.R100038200 – volume: 12 start-page: 468 year: 2000 ident: B150 article-title: Intra-articular hyaluronan therapy publication-title: Curr Opin Rheumatol doi: 10.1097/00002281-200009000-00022 – volume: 200 start-page: 415 year: 1981 ident: B86 article-title: Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit publication-title: Biochem J doi: 10.1042/bj2000415 – ident: B257 – ident: B102 – volume: 24 start-page: 219 year: 1990 ident: B91 article-title: The role of liver and kidneys in the removal of circulating hyaluronan. An experimental study in the rat publication-title: Connect Tiss Res doi: 10.3109/03008209009152150 – volume: 4 start-page: 28 year: 2013 ident: B220 article-title: Efficacy evaluation of a new hyaluronan derivative HYADD® 4-G to maintain cartilage integrity in a rabbit model of osteoarthritis publication-title: Cartilage doi: 10.1177/1947603512455193 – volume: 8 start-page: 397 year: 2008 ident: B16 article-title: Hyaluronic acid. (hyaluronan): a review publication-title: Vet Med. doi: 10.17221/1930-VETMED – volume: 27 start-page: 230 year: 2019 ident: B103 article-title: Models of osteoarthritis: the good, the bad and the promising publication-title: Osteoarthr Cartil doi: 10.1016/j.joca.2018.09.016 – volume: 18 start-page: 428 year: 1991 ident: B229 article-title: Hypertrophic repair of canine articular cartilage in osteoarthritis after anterior cruciate ligament transection publication-title: J Rheumatol – volume: 109 start-page: 927 year: 1989 ident: B276 article-title: Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types publication-title: J Cell Biol doi: 10.1083/jcb.109.2.927 – start-page: 161 volume-title: Nutraceuticals: Efficacy, Safety and Toxicity. year: 2016 ident: B42 article-title: Nutraceuticals in arthritis doi: 10.1016/B978-0-12-802147-7.00013-9 – volume: 24 start-page: 244 year: 2005 ident: B168 article-title: Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis publication-title: Clin Rheumatol doi: 10.1007/s10067-004-1013-5 – volume: 22 start-page: 579 year: 2014 ident: B281 article-title: Hyaluronan in wound healing: rediscovering a major player publication-title: Wound Repair Regener doi: 10.1111/wrr.12214 – volume: 41 start-page: 568 year: 1980 ident: B242 article-title: Effect of hyaluronic acid in naturally occurring and experimentally induced osteoarthritis publication-title: Am J Vet Res – volume: 250 start-page: 418 year: 1998 ident: B128 article-title: Chondrocyte apoptosis increases with age in the articular cartilage of adult animals publication-title: Anat Rec doi: 10.1002/(SICI)1097-0185(199804)250:4<418::AID-AR4>3.3.CO;2-B – volume: 380 start-page: 2197 year: 2012 ident: B104 article-title: Disability-adjusted life years. (DALYs). for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet doi: 10.1016/S0140-6736(12)61690-0 – volume: 10 start-page: 26 year: 2013 ident: B191 article-title: A hexadecylamide derivative of hyaluronan. (HYMOVIS®). has superior beneficial effects on human osteoarthritic chondrocytes and synoviocytes than unmodified hyaluronan publication-title: J Inflamm. doi: 10.1186/1476-9255-10-26 – volume: 44 start-page: 1800 year: 2001 ident: B202 article-title: Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54. (intercellular adhesion molecule 1). involvement publication-title: Arthr Rheum doi: 10.1002/1529-0131(200108)44:8<1800::AID-ART317>3.0.CO;2-1 – volume: 17 start-page: 379 year: 1976 ident: B238 article-title: Intra-articular treatment of arthritis in racehorses with sodium hyaluronate publication-title: Acta Vet Scand doi: 10.1186/BF03547893 – ident: B59 – volume: 14 start-page: 159 year: 2011 ident: B140 article-title: Chondrocyte apoptosis: a cause or consequence of osteoarthritis? publication-title: Int J Rheum Dis doi: 10.1111/j.1756-185X.2011.01618.x – volume: 146 start-page: 75 year: 1995 ident: B127 article-title: Chondrocyte apoptosis induced by nitric oxide publication-title: Am J Pathol – volume: 6 start-page: 9313 year: 2015 ident: B311 article-title: Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer publication-title: Oncotarget doi: 10.18632/oncotarget.3220 – volume: 14 start-page: 1011 year: 2006 ident: B139 article-title: Mitochondrial activity is modulated by TNFalpha and IL-1β in normal human chondrocyte cells publication-title: Osteoarthr Cartil doi: 10.1016/j.joca.2006.03.008 – volume: 17 start-page: 1871 year: 1997 ident: B308 article-title: Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines publication-title: Anticancer Res – volume: 5 start-page: 54 year: 2003 ident: B14 article-title: Intra-articular hyaluronan. (hyaluronic acid) and hyalans for the treatment of osteoarthritis: mechanism of action publication-title: Arthr Res Ther. doi: 10.1186/ar623 – volume: 25 start-page: 1199 year: 2017 ident: B208 article-title: Chondrocyte secretome: a source of novel insights and exploratory biomarkers of osteoarthritis publication-title: Osteoarthr Cartil doi: 10.1016/j.joca.2017.02.797 – volume: 67 start-page: 183 year: 1999 ident: B197 article-title: in vitro stimulation of equine articular cartilage proteoglycan synthesis by hyaluronan and carprofen publication-title: Res Vet Sci doi: 10.1053/rvsc.1999.0328 – volume: 96 start-page: 536e41 year: 2013 ident: B300 article-title: Enhanced corneal wound healing with hyaluronic acid and high-potassium artificial tears publication-title: Clin Exp Optom doi: 10.1111/cxo.12073 – volume: 99 start-page: 501 year: 2002 ident: B189 article-title: Elastoviscous substances with analgesic effects on joint pain reduce stretch-activated ion channel activity in vitro publication-title: Pain doi: 10.1016/S0304-3959(02)00260-9 – volume: 83 start-page: 317 year: 2004 ident: B30 article-title: Hyaluronan catabolism: A new metabolic pathway publication-title: Eur J Cell Biol doi: 10.1078/0171-9335-00392 – volume: 5 start-page: 12775 year: 2015 ident: B125 article-title: MiR-210 inhibits NF-kappaB signaling pathway by targeting DR6 in osteoarthritis publication-title: Sci Rep doi: 10.1038/srep12775 – start-page: 61 volume-title: Disorders of the Knee year: 1982 ident: B163 article-title: The physical properties of synovial fluid and the special role of hyaluronan acid – volume: 14 start-page: 154 year: 2006 ident: B264 article-title: A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee publication-title: Osteoarthr Cartil doi: 10.1016/j.joca.2005.09.003 – volume: 76 start-page: 695 year: 1991 ident: B88 article-title: Catabolism of hyaluronan in rabbit skin takes place locally in lymph nodes and liver publication-title: Exp Physiol doi: 10.1113/expphysiol.1991.sp003536 – volume: 202 start-page: 83 year: 2015 ident: B305 article-title: Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy publication-title: J Controll Rel doi: 10.1016/j.jconrel.2015.01.030 – volume: 2018 start-page: 10 year: 2018 ident: B316 article-title: Hyaluronic acid decorated naringenin nanoparticles: Appraisal of chemopreventive and curative potential for lung cancer publication-title: Pharmaceutics. doi: 10.3390/pharmaceutics10010033 – volume: 92 start-page: 1162 year: 2010 ident: B74 article-title: Effect of hyaluronic acid amide derivative on equine synovial fluid viscoelasticity publication-title: J Biomed Mater Res A doi: 10.1002/jbm.a.32455 – volume: 22 start-page: 2104 year: 2017 ident: B9 article-title: Novel artificial tears containing cross-linked hyaluronic acid: an in vitro re-epithelialization study publication-title: Molecules doi: 10.3390/molecules22122104 – volume: 12 start-page: 60 year: 2016 ident: B244 article-title: A randomized, double-blinded, placebo-controlled clinical study on intra-articular hyaluronan treatment in equine lameness originating from the metacarpophalangeal joint publication-title: BMC Vet Res doi: 10.1186/s12917-016-0687-7 – volume: 77 start-page: 1064 year: 2016 ident: B249 article-title: Efficacy of intravenous administration of hyaluronan, sodium chondroitin sulfate, and N-acetyl-D-glucosamine for prevention or treatment of osteoarthritis in horses publication-title: Am J Vet Res doi: 10.2460/ajvr.77.10.1064 – volume: 15 start-page: 520 year: 2016 ident: B293 article-title: Physicochemical properties and application of hyaluronic acid: a systematic review publication-title: J Cosmet Dermatol doi: 10.1111/jocd.12237 – volume: 10 start-page: 1133 year: 2018 ident: B22 article-title: Hyaluronic acid-based nanomaterials for cancer therapy publication-title: Polymers doi: 10.3390/polym10101133 – volume: 32 start-page: 10 year: 2002 ident: B25 article-title: Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis; are the effects molecular weight dependent? publication-title: Sem Arthr Rheum doi: 10.1053/sarh.2002.33720 – volume: 49 start-page: 116 year: 2017 ident: B115 article-title: Characterization of lubricin in synovial fluid from horses with osteoarthritis publication-title: Equine Vet J doi: 10.1111/evj.12521 – volume: 97 start-page: 186 year: 2016 ident: B8 article-title: Hyaluronan as a therapeutic target in human diseases publication-title: Adv Drug Deliv Rev. doi: 10.1016/j.addr.2015.10.017 – volume: 14 start-page: 1150 year: 1987 ident: B232 article-title: Studies of synovial hyaluronic acid synthesis in canine osteoarthritis publication-title: J Rheumatol – volume: 14 start-page: 1150 year: 1987 ident: B226 article-title: Studies of synovial hyaluronic acid synthesis in canine osteoarthritis publication-title: J Rheumatol – volume: 17 start-page: 30 year: 1986 ident: B304 article-title: The place of sodium hyaluronate in glaucoma surgery publication-title: Ophthalmic Surg – volume: 8 start-page: 17 year: 2000 ident: B133 article-title: Induction of apoptosis in bovine articular chondrocyte by prostaglandin E2 through cAMP-dependent pathway publication-title: Osteoarthr Cartil doi: 10.1053/joca.1999.0266 – volume: 9 start-page: 3427 year: 2018 ident: B109 article-title: Dysregulation of the NUDT7-PGAM1 axis is responsible for chondrocyte death during osteoarthritis pathogenesis publication-title: Nat Commun doi: 10.1038/s41467-018-05787-0 – volume: 103 start-page: 576 year: 1994 ident: B282 article-title: Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin publication-title: J Invest Dermatol doi: 10.1111/1523-1747.ep12396880 – volume: 3 start-page: 299 year: 1995 ident: B283 article-title: Hyaluronan, heterogeneity, and healing: the effects of ultrapure hyaluronan of defined molecular size on the repair of full-thickness of pig skin wounds publication-title: Wound Repair Reg doi: 10.1046/j.1524-475X.1995.30310.x – volume: 4 start-page: 99 year: 1996 ident: B195 article-title: Effect of high molecular weight hyaluronan on cartilage degeneration in a rabbit model of osteoarthritis publication-title: Osteoarthr Cartil doi: 10.1016/S1063-4584(05)80319-X – volume: 14 start-page: 571 year: 2012 ident: B259 article-title: Role of slow-acting anti-arthritic agents in osteoarthritis. (chondroitin sulfate, glucosamine, hyaluronic acid) publication-title: Rev Med Suisse – volume: 242 start-page: 27 year: 1997 ident: B29 article-title: Hyaluronan: Its nature, distribution, functions and turnover publication-title: J Intern Med doi: 10.1046/j.1365-2796.1997.00170.x – volume: 23 start-page: 398 year: 2013 ident: B40 article-title: Hypotheses on the evolution of hyaluronan: a highly ironic acid publication-title: Glycobiology doi: 10.1093/glycob/cws218 – volume: 16 start-page: 1718 year: 2009 ident: B61 article-title: Role, metabolism, chemical modifications and applications of hyaluronan publication-title: Curr Med Chem doi: 10.2174/092986709788186138 – volume: 39 start-page: 1718 year: 2016 ident: B122 article-title: MicroRNA-142-3p inhibits chondrocyte apoptosis and inflammation in osteoarthritis by targeting HMGB1 publication-title: Inflammation doi: 10.1007/s10753-016-0406-3 – volume: 41 start-page: 976 year: 1998 ident: B233 article-title: Effect of intraarticular hyaluronan injection in experimental canine osteoarthritis publication-title: Arthr Rheumatol doi: 10.1002/1529-0131(199806)41:6<976::AID-ART4>3.0.CO;2-R – volume: 82 start-page: 38 year: 2011 ident: B290 article-title: A review of hyaluronan and its ophthalmic applications publication-title: Optometry doi: 10.1016/j.optm.2010.08.003 – volume: 55 start-page: 163 year: 2017 ident: B294 article-title: Targeted delivery of hyaluronic acid to the ocular surface by a polymer-peptide conjugate system for dry eye disease publication-title: Acta Biomater doi: 10.1016/j.actbio.2017.03.043 – volume: 250 start-page: 435 year: 1988 ident: B41 article-title: Hyaluronic acid in human articular cartilage. Age-related changes in content and size publication-title: Biochem J doi: 10.1042/bj2500435 – volume: 27 start-page: 219 year: 2019 ident: B231 article-title: The protective effect of anterior cruciate ligament reconstruction on articular cartilage: a systematic review of animal studies publication-title: Osteoarthr Cartil doi: 10.1016/j.joca.2018.10.001 – volume: 14 start-page: 1237 year: 2006 ident: B182 article-title: High molecular-weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis publication-title: Osteoarthr Cartil doi: 10.1016/j.joca.2006.05.009 – volume: 254 start-page: 6252 year: 1979 ident: B1 article-title: Biosynthesis of hyaluronic acid by Streptococcus publication-title: J Biol Chem. doi: 10.1016/S0021-9258(18)50356-2 – volume: 61 start-page: 22 year: 1984 ident: B162 article-title: Hyaluronic acid concentration in synovial fluid from normal and arthritic joints of horses publication-title: Austr Vet J doi: 10.1111/j.1751-0813.1984.tb07125.x – volume: 287 start-page: 43094 year: 2012 ident: B55 article-title: The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering publication-title: J Biol Chem doi: 10.1074/jbc.M112.349209 – volume: 47 start-page: 1172 year: 2008 ident: B207 article-title: Significant synovial pathology in a meniscectomy model of osteoarthritis: Modification by intra-articular hyaluronan therapy publication-title: Rheumatology doi: 10.1093/rheumatology/ken219 – volume: 5 start-page: 236 year: 1985 ident: B240 article-title: Notes on the use of sodium hyaluronate in Thoroughbreds publication-title: J EVS doi: 10.1016/S0737-0806(85)80106-4 – ident: B159 – volume: 15 start-page: 7 year: 2017 ident: B315 article-title: Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44 publication-title: J Nanobiotechnol doi: 10.1186/s12951-016-0245-2 – volume: 73 start-page: 259 year: 1995 ident: B284 article-title: Angiogenesis is a delayed vascularization model is accelerated by angiogenic oligosaccharides of hyaluronan publication-title: Lab Invest – volume: 73 start-page: 222 year: 2015 ident: B328 article-title: Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancer publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2014.11.026 – volume: 12 start-page: 228 year: 2012 ident: B326 article-title: Metastasis: multitasking hyaluronic acid publication-title: Nat Rev Cancer doi: 10.1038/nrc3254 – volume: 5 start-page: 153 year: 1997 ident: B260 article-title: Arthroscopic evaluation of potential structure modifying activity of hyaluronan. (Hyaglan) in osteoarthritis of the knee publication-title: Osteoarthr Cartil doi: 10.1016/S1063-4584(97)80010-6 – volume: 40 start-page: 62 year: 1996 ident: B295 article-title: Sodium hyaluronate eyedrops enhance tear film stability publication-title: Jap J Ophthalmol – volume: 23 start-page: 443 year: 2007 ident: B248 article-title: An evidence-based approach to selected joint therapies in horses publication-title: Vet Clin North Am: Equine Pract doi: 10.1016/j.cveq.2007.04.007 – volume: 40 start-page: 1749 year: 1997 ident: B135 article-title: Fas/Fas ligand expression and induction of apoptosis in chondrocytes publication-title: Arthr Rheumatol doi: 10.1002/art.1780401004 – volume: 27 start-page: 1713 year: 2000 ident: B198 article-title: Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis publication-title: J Rheumatol – volume: 11 start-page: 636 year: 2003 ident: B219 article-title: Long-term effect of sodium hyaluronate. (Hyalgan®) on osteoarthritis progression in a rabbit model publication-title: Osteoarthr Cartil doi: 10.1016/S1063-4584(03)00119-5 – volume: 41 start-page: 1240 year: 2002 ident: B262 article-title: Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicenter study publication-title: Rheumatology doi: 10.1093/rheumatology/41.11.1240 – volume: 30 start-page: 192 year: 1981 ident: B186 article-title: Effect of exogenous hyaluronic acid on joint function in experimentally induced equine osteoarthritis: Dosage titration studies publication-title: Res Vet Sci doi: 10.1016/S0034-5288(18)32580-3 – volume: 52 start-page: 817 year: 1993 ident: B78 article-title: Effects of molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats publication-title: Ann Rheum Dis doi: 10.1136/ard.52.11.817 – volume: 594 start-page: 61 year: 2016 ident: B121 article-title: MicroRNA-26a-5p regulates the expression of inducible nitric oxide synthase via activation of NF-kappaB pathway in human osteoarthritis chondrocytes publication-title: Arch Biochem Biophys doi: 10.1016/j.abb.2016.02.003 |
SSID | ssj0001547380 |
Score | 2.603765 |
SecondaryResourceType | review_article |
Snippet | Hyaluronic acid (also known as hyaluronan or hyaluronate) is naturally found in many tissues and fluids, but more abundantly in articular cartilage and... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 192 |
SubjectTerms | hyaluronan hyaluronic acid ophthalmic diseases osteoarthritis Veterinary Science viscosupplementation wound healing |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQnrig3fLK8lCQuHCI6viVeE8URFUhlVOLeov8iigq6YqmSP33O-OkpUEruHDJIbEV65uxPWPPfEPIW6s1zAMeMsEdPKShmTWlyJhz4MfRWiuDRwPzL2q2FJ9XcnVW6gtjwjp64A64cShzo50vKbdShFLpMtRFqT1slTq43OLqSzU9c6a6_GBR8JJ295Lghelx_Su0SM-dR35KzQb7UKTrv8_G_DNU8mzvmV6SR73RmE66wV6RB6EZkdFXjGSJ6bTpvL8hf0zezw5ms4-Et-nErf1NOj8WwIVWmOa73v3Ypabx6eJ36lUKW9b3eH5_eEKW00-Lj7Osr5KQOaFYm_nCCQmAA0w5M0i-U3vhhCl4sN7BdNa29oVURgRmak5NLi0VwlKJWdRG86fkotk24TlJwVu01NugVBkEE9wgYWLOHeOuZtA9IeMjZpXrKcSxksWmAlcCUa4iyhWiXEWUE_Lu1OO2o8_4S9sPKIZTOyS-ji9AHapeHap_qUNC3hyFWMFEwdsP04TtHn7E0FSEFUwl5Fkn1NOvOFg9gnKZkGIg7sFYhl-a9bdIxq2wTHchr__H4F-QhwgHRqIx-ZJctD_34RXYPK19HdX7DpGtAKU priority: 102 providerName: Directory of Open Access Journals |
Title | Hyaluronic Acid: Molecular Mechanisms and Therapeutic Trajectory |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31294035 https://www.proquest.com/docview/2256101836 https://pubmed.ncbi.nlm.nih.gov/PMC6603175 https://doaj.org/article/e81a9cd803b54e8698ef789d0669ec1b |
Volume | 6 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwELYQXLggCrSkDxQkLhwCiV-JK1WUItAKaTmxiFvkV2CrbbbdB2L_fWec7NKtVkhcIiWx43jG45mxPd8QcmSUAjlgPuHMwkXoNDG64Am1Fvy4tFJS49JA90Z2evz6Xty_hEe3BByvdO0wn1RvNDh5_jM7A4H_hh4n6NvT6slPEHk7C9CTCibkjbBbhAf5WmO_iRnmOQup1ChVARlRNfuWKz-ypKcCnP8qG_T_o5T_6KarbbLVGpXxeTMK3pE1X--QnTs86RLCbeNuu4O-S753ZnowDYC48bntu69xd54gF0phGHB__Gsc69rFty-hWTGotJ9hfX-2R3pXl7cXnaTNopBYLukkcbnlAhiSaZVRjeA8leOW65x54yyIuzKVy4XU3FNdsVRnwqScm1RglLVW7D1Zr4e13ycxeJMmdcZLWXhOOdMIqJgxS5mtKFSPyOmcZqVtIcYx08WgBFcDqVwGKpdI5TJQOSLHixq_G3iNV8r-QDYsyiEwdngwHD2UrZyVvoB-WlekzAjuC6kKX-WFcmBZKW8zE5HDORNLECTcHdG1H06hIYqmJMxwMiIfGqYummJgFfGUiYjkS-xe-pflN3X_MYB1S0zjnYuPb-joJ7KJN3ggjYrPZH0ymvovYPpMzEFYMjgI4_ovtjkCfg |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hyaluronic+Acid%3A+Molecular+Mechanisms+and+Therapeutic+Trajectory&rft.jtitle=Frontiers+in+veterinary+science&rft.au=Gupta%2C+Ramesh+C.&rft.au=Lall%2C+Rajiv&rft.au=Srivastava%2C+Ajay&rft.au=Sinha%2C+Anita&rft.date=2019-06-25&rft.issn=2297-1769&rft.eissn=2297-1769&rft.volume=6&rft_id=info:doi/10.3389%2Ffvets.2019.00192&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fvets_2019_00192 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2297-1769&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2297-1769&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2297-1769&client=summon |